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Chapter 1
General Introduction, Objectives and Outline of this thesis
Parts of this introduction were published as a symposium proceeding in: 
Néphrologie Périnatale (5): Développement rénal et programmation
des maladies cardiovasculares 2004, 127-133 ISBN: 2-84299-619-4.
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GENERAL INTRODUCTION
With increasing morbidity and mortality of cardiovascular disease and end stage re-
nal disease, risk factors contributing to these diseases are frequently studied in the 
last years.1;2 Besides some well known factors (e.g., smoking, obesity, hypertension 
and type II diabetes) also early determinants, such as intrauterine undernutrition, 
rapid postnatal growth, and prematurity are suggested to increase the susceptibil-
ity to these diseases. The associations between early determinants and increased 
susceptibility to adult diseases is also known as the ‘developmental origins of adult 
health and disease’ hypothesis.3-5 
In this thesis several aspects of the ‘developmental origins of adult health and dis-
ease’ hypothesis are discussed, focussed on renal development, adult renal function 
and hypertension. After this general introduction the objectives and outline of this 
thesis are described.
‘Developmental origins of adult health and disease’ hypothesis
In 1986 a correlation between birth weight and ischaemic heart disease in adults 
in England and Wales was suggested.6 In this study (post)neonatal mortality in the 
period of 1921 – 1925 was positively related to ischaemic heart disease in the same 
regions in the period of 1968-1978. Also other diseases (bronchitis, stomach cancer 
and rheumatic heart disease) were related to infant mortality, suggesting that poor 
living conditions, including poor nutrition, in early life is an important determinant 
in development of disease on the short and long run. Furthermore, weight at the 
age of 1 year was negatively related to cardiovascular mortality at adult age.7 There-
fore, it was suggested that processes linked to growth and acting in prenatal or early 
postnatal life strongly influence the risk of ischaemic heart disease. Associations 
between fetal growth, (early) postnatal growth and adult weight and body com-
position have been demonstrated.8-10 Many studies concerning this ‘developmental 
origins of adult health and diseases’ hypothesis (formerly known as ‘fetal origins 
of adult diseases’ or ‘Barker’ hypothesis) are published in the years thereafter.11-14 
A relation between prenatal or postnatal circumstances and the development of 
adult cardiovascular disease and hypertension, insulin resistance and diabetes 
mellitus type II4;15;16, obesity and the metabolic syndrome8;9, renal disease17;18, and 
the hypothalamo-pituitary adrenal axis19;20 has been documented in both animal 
experiments and in human observational studies.
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Also the effect of accelerated postnatal growth in weight and length are suggested 
to increase the risk for developing hypertension and type II diabetes in later life, 
especially in low birth weight individuals. 
Thriphty phenotype hypothesis, programming and developmental plasticity.
Redistribution of nutrients in favour of the development of the brain is an important 
consequence to survive insufficient fetal nutrition. Maternal malnutrition (insuffi-
cient intake or unbalanced nutrients) and placenta insufficiency are the most com-
mon causes of fetal malnutrition and intrauterine growth retardation (IUGR).21 Fetal 
nutrient redistribution leads to changes in cardiac output, hormone production, 
and sensitivity to hormones.22 These changes are thought to affect development 
of lungs, pancreas and kidneys. Adaptation to the ‘low nutrient’ situation may lead 
to an increased susceptibility for malfunction of these specific organs after birth 
when this ‘low nutrient’ situation is discontinued.23 Terms as ‘thriphty phenotype’ 
hypothesis, ‘developmental plasticity’, ‘programming’, all refer to this ability of ad-
aptation.24 
It is likely that organs and organ system are affected most when undernourish-
ment is present in the period of their ‘critical window’ of development. In the Dutch 
famine studies it was demonstrated that undernutrition in early gestation led to an 
increase in coronary heart disease, atherogenic lipid and thrombotic blood profile, 
and obesity. 25 Mid-gestation undernutrition increased the obstructive airway dis-
ease and microalbuminuria prevalence, and undernutrition during late gestation 
mainly increased glucose tolerance.25 
Besides nutrition, other environmental factors, such as hypoxia, stress, and vitamin 
A deficiency, and variation in genes and changes in genetic expression have been 
linked to early development and adult diseases susceptibility.26-29 Also maternal 
factors, such as age, maternal diabetes, hypertension during pregnancy, maternal 
smoking during pregnancy, and maternal genetic factors may influence the meta-
bolic pathway in the offspring.17;30-32 Future studies are warranted to elucidate the 
role of these factors. 
Pathophysiological mechanisms
Several pathways have been proposed as possible explanations for the occurrence 
of adult diseases after IUGR, and reviewed by McMillen et al.33 Pancreatic under-
development with β-cell dysfunction, upregulation and downregulation of hepatic 
glucose-related cell receptors, and development and function of the adipocyte and 
smooth muscle cells all seem to contribute to the development of glucose toler-
ance, insulin resistance and type II diabetes in IUGR individuals.33 Development of 
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cardiovascular disease and hypertension may be explained by alterations in the 
renin-angiotensin-system, (vascular) endothelial dysfunction, and impaired renal 
development with a nephron deficit.33 Also the occurrence of (end-stage) renal dis-
ease during life is linked to this impaired (fetal) renal development after IUGR.34
Renal involvement
Nephron endowment
A relation between a reduced nephron number and development of essential hy-
pertension has been long recognized, also known as the ‘hyperfiltration theory’.35 
This theory enables to understand the possible biological mechanism in the hy-
pothesis that renal diseases at adult age is associated with IUGR (Figure 1).36-38 Pre-
natal malnutrition may lead to IUGR and impairment of renal development includ-
ing deficit in nephron numbers, which causes a decreased filtration surface area. 
Renal hemodynamic alterations, like (single-nephron) hyperfiltration, are needed to 
optimalize the glomerular filtration in order to maintain normal renal function. 36-38 
This phenomenon is accompanied by glomerular and systemic hypertension36-38, as 
also demonstrated in individuals with unilateral agenesis and ablative surgery in 
kidney donors.39;40 Persistent glomerular hypertension causes damage of nephrons 
leading to acquired glomerular sclerosis.41 Nephron number decreases followed by 
a decrease in filtration surface area (vicious circle) eventually resulting in (end stage) 
renal disease.36-38 
Figures and Legends 
Figuren horende bij Hoofdstuk 1 (introductie) 
Intra Uterine Growth Retardation (IUGR) 
Impaired renal development with nephron deficit 
Reduction in filtration surface area 
(Single nephron) hyperfiltration to maintain GFR 
Glomerular hypertension 
Acquired glomerular sclerosis 
End stage renal disease 
Figure 1: Brenners Hyperfiltration theory. 38
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Recently, data are published showing a strong relation between birth weight and 
renal size, nephron number, albuminuria and systolic blood pressure in Aboriginal 
communities.34 In these communities, diseases like type II diabetes, cardiovascular 
diseases and renal diseases take epidemic proportions.42;43 In 668 aboriginals be-
tween 4 and 72 years, those individuals with the lowest birth weights had smallest 
kidneys (measured by ultrasound), and the individuals with the smallest kidney 
size had the highest blood pressure and the highest rates of albuminuria (ACR ≥ 
34 mg/mmol).34 In the children (n=210 < 15 years), with a 1 cm increase in mean 
kidney length systolic blood pressure decreased with 3.2 mmHg.34 Another study 
in 56 deceased African Americans and Caucasians the kidneys were microscopically 
investigated.44 Nephron number, measured by stereologic estimation, was related 
to birth weight. Nephron number also was inversely related to glomerular volume, 
suggesting that glomerulomegaly is a marker of an increased risk of groups of 
patients or populations with progressive renal disease.45;46 These findings support 
Brenners ‘hyperfiltration theory’ indicating that birth weight is a risk factor for the 
development of progressive renal disease. 36
Renin-Angiotensin-System
The renin-angiotensin-system (RAS) is important in the regulation of systemic and 
glomerular blood pressure. A decreased renal blood flow leads to an increase in the 
production of renin by juxta-glomerular apparatus, and increased blood pressure in 
two ways. First, renin is converted into angiotensin I (AT I), which is converted into 
angiotensin II (AT II) by angiotensin-converted enzyme (ACE). AT II stimulates α-re-
ceptors causing vasoconstriction in small vessels leading to an increase in systemic 
blood pressure. Second, AT II stimulates aldosterone hormone production in the 
adrenal glands that stimulates sodium reabsorption and water retention in the distal 
tubulus leading to an increase of circulating volume and systemic blood pressure.47
In addition to the role of blood pressure regulation, the RAS is also thought to be 
an important factor in the fetal renal development.48 Renal structural abnormali-
ties, such as papillary atrophy and pelvic dilatation, are shown in animals in whom 
RAS was blocked during renal development.49 Furthermore, nephrovascular devel-
opment was impaired in rats after ATII1 receptor blockade, with extensive vascular 
abnormalities of the afferent arteriolae and cortical radial arteries.50 In humans, 
oligohydramnios and prolonged neonatal anuria have been reported after fetal 
exposure to ACE inhibitors.51;52 
Besides these structural changes, increased blood pressure, decreased renal 
function, and altered renin concentrations were observed after birth in rats after 
RAS suppression during nephrogenesis.53-55 However, literature on this topic is frag-
mented. Experimental studies have demonstrated RAS suppression in the offspring 
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of protein restricted pregnant rats.56 This was also associated with a inhibition of 
nephrogenesis and development of the ascending limb of Henle.56 Also, increased 
ATII1 receptor expression was shown in undernutritioned fetal rats.
57 This may be 
a direct effect of protein restriction or a response to a decreased ATII concentra-
tion.57 
In humans, Konje studied the active renin levels and AT I levels in the umbilical 
vein in preterms and IUGR human fetuses.58 AT I levels were increased in IUGR in-
fants born preterm. Hypoxia, increased sympatic nerve activity and catecholamin 
production (all present in IUGR fetuses), but also proliferation of juxta-glomerular 
cells (and thus renin producing cells) were suggested to be involved. Martyn showed 
a decreased inactive renine concentration in human adults exposed to malnutrition 
and IUGR.59 The differences in study design, exposure and outcome variables (e.g., 
(in)active renin, ATI, ATII, ATII receptor) make studies hard to compare. Also the as-
sociation between fetal alterations in RAS activity and adult blood pressure or renal 
function are not convincing. Large field of research unclear biological pathway. Fur-
ther investigations are needed to elucidate the role of RAS in fetal kidney develop-
ment and the association with adult hypertension and renal function loss.
Gestational age and the ‘developmental origins of adult health and disease’ hypothesis 
In humans, rapid development of important functional cell structures in the lungs, 
pancreas and kidneys takes place until the last few weeks of gestation and preterm 
birth may affect final development.60-62 For example, nephrogenesis continues the 
gestational age of 36 weeks.62 It has been suggested that premature birth impairs 
final development of nephrons (after birth).63;64 This was observed in 56 deceased 
premature infants with extremely low birth weight (birth weight ≤ 1000 gram of 
which 25% SGA) and 10 deceased full term born controls with normal birth weight.63 
Nephron number was highly correlated to gestational age and active glomerulo-
genesis was ceased after 40 days postnatal. Therefore, a reduced nephron number 
after preterm birth persists throughout life and may affect long-term renal function 
and blood pressure. 
Several studies support the hypothesis that preterm birth may have an additional 
effect to low birth weight in the increased risk for diseases in later life.5;65-67 A large 
Swedish study showed an inverse association between GA, ranging from 35 - 44 
weeks, and systolic BP (SBP) in 165,136 Swedish men.5 This correlation may be stron-
ger in the lower range of gestation (GA 30-38 weeks).65 Similar results were found 
in young adult women between 23 and 30 years of age.66;67 Systolic blood pressure 
and the number of hypertensive blood pressure readings were only increased in the 
preterm born individuals with appropriate birth weight, and not in full term born 
controls (either IUGR or with appropriate birth weight).
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Moreover, it was suggested that growth and development during the third trimes-
ter after conception of the preterm infant was more important in development of 
cardiovascular risk factors than intrauterine growth retardation alone.68 Adult blood 
pressure and fasting glucose levels were higher in individuals who were born very 
premature compared with normal birth weight controls. No difference between the 
individuals who were born very premature with IUGR or appropriate birth weight 
was present. Other studies comparing individuals who were born very premature 
with either low or appropriate birth weight are scarce.69
 
In this thesis we describe the long term follow-up of very premature born individu-
als, both small and appropriate for gestational age and compared the results with 
full term born controls with appropriate birth weight.
OBJECTIVES OF THIS THESIS
The main objectives of the studies described in this thesis were to evaluate the ef-
fect of premature birth and of IUGR within very preterm born individuals on blood 
pressure and renal function at young adult age. Two studies were conducted to 
answer the following research questions:
1.  Is IUGR a predisposing factor for increased blood pressure at young adult age 
within individuals who were born very premature? 
2.  Is blood pressure increased at young adult age in individuals who were born very 
premature and IUGR compared with individuals who were born very premature 
with appropriate birth weight, and with full term born controls? 
3.  Is IUGR a predisposing factor for decreased renal function at young adult age 
within individuals who were born very premature? 
4.  Are renal function and renal functional reserve capacity (RFRC) impaired in indi-
viduals who were born very premature and IUGR compared with individuals who 
were born very premature with appropriate birth weight, and with full term born 
controls at young adult age?
5.  Do individuals who were born IUGR and / or prematurely have smaller (relative) 
kidney size at young adult age compared with full term born controls?
6.  Is there an association between renal size, renal function, renal functional reserve 
capacity, and blood pressure in very preterm born individuals and in controls? or 
Do subjects with an increased blood pressure also have a decreased renal func-
tion and a decreased renal size?
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Blood pressure and renal function were obtained from the individuals who partici-
pated in the follow-up visit at the age of 19 years of the 1983 very preterm birth 
cohort (Project On Prematures and Small for gestational age infants: POPS) between 
April 2002 and May 2003. Additionally, we examined renal function, renal functional 
reserve capacity, renal size, and 24-hour blood pressure in 52 individuals who were 
born very premature and in 30 controls in the ErasmusMC-Sophia Children’s Hos-
pital, University Medical Center Rotterdam, The Netherlands between October 16th 
2003 and November 18th 2004.
OUTLINE OF THIS THESIS
In the first chapter of this thesis an overview of the literature is given, followed by 
the main objectives and outline of this thesis. Chapter 2 describes a statistical ap-
proach in the analyses of the ‘developmental origins of adult health and disease’ 
hypothesis. The study methods of the POPS 19 study are described in Chapter 3.1 
followed by the results on blood pressure (Chapter 3.2) and renal function (Chapter 
3.3). Chapter 4.1 describes the methods of the POPS Nephrology study. The results 
of this study on blood pressure (Chapter 4.2), renal function (Chapter 4.3) and renal 
ultrasound (Chapter 4.4) are discussed in the following chapters. The general dis-
cussion (Chapter 5) answers the main research questions of this thesis, as described 
in Chapter 1.

Chapter 2
Analysing the ‘fetal origins of adult diseases hypothesis’ 
using a regression model with ‘unexplained residuals’ 
MG Keijzer-Veen, AM Euser, AG van Montfoort, FW Dekker, 
JP Vandenbroucke, JC van Houwelingen.
J Clin Epidemiol 2005;58(12);1320-1324
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ABSTRACT
Background and objective: A continued controversy exists whether the assessment of 
the influence of low birth weight on adult blood pressure necessitates adjustment 
for adult weight in the analysis on the fetal origins of adult diseases hypothesis. 
Here we first explain the difficulty in understanding an adjusted multivariate regres-
sion model, and second to propose another way of writing the regression model to 
make the interpretation of the separate influence of birth weight and changes in 
weight later in life more straightforward. 
Methods: We used a multivariate regression model containing birth weight (SDS), 
and residual adult weight (SDS) to explore the effect on blood pressure (or any 
other outcome) separately. Residual adult weight was calculated as the difference 
between actual adult weight and the expected adult weight (SDS) given on a cer-
tain birth weight (SDS).
Results: The coefficients of birth weight and residual adult weight show directly the 
effect on the analysed outcome variable. 
Conclusions: We prefer to use this regression model with unexplained residuals 
when the adjusted variable is in the causal pathway in the analyses of data referring 
to the fetal origins of adult diseases hypothesis. 
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INTRODUCTION
In the literature on the fetal origins hypothesis, a continued controversy exists 
whether the assessment of the influence of low birth weight on adult blood pres-
sure necessitates adjustment for adult weight 70;71. The controversy was fueled by 
the meta-analysis of Huxley et al. who described little or no relation between birth 
weight and adult blood pressure if unadjusted for adult weight, and implied that 
such adjustment might even be misleading 72. The effect of adding adult weight as 
a variable in the regression of blood pressure on weight at birth is intricate: a review 
by Lucas et al. suggested that such a regression model should in fact be interpreted 
as the influence of a change in weight between birth and adulthood – and no lon-
ger as the influence of birth weight 73. Nonetheless, the interpretation of data by this 
concept remains confusing.
Our objective here is first to explain the difficulty in understanding the adjusted 
regression for the general reader, and then to propose another way of writing the 
regression model to make the interpretation of the separate influence of birth 
weight and changes in weight later in life more straightforward. We will explain the 
model not only conceptually and algebraically, but also by an example on data from 
an ongoing study on the effect of birth weight on blood pressure. Validation of the 
model in future analysis is warranted. 
The adjusted regression analysis
Originally the association between birth weight and adult blood pressure was main-
ly analysed without adjustments for additional variables 74. Later, it was shown that 
subjects born with low birth weight tended to gain more weight compared with 
subjects born with a normal birth weight. Weight gain alone was also associated 
with an increased risk for high blood pressure. Therefore, adult weight was seen as 
a potential confounder in the analysis, and adjustment for it became more common 
12. Some articles, however, found a significant association between birth weight and 
adult diseases only after adjustment for adult weight 75. Therefore, the need for a 
multivariate regression model incorporating the effects of both birth weight and 
adult weight seemed to be the most promising statistical approach. Still, the inter-
pretation of what was achieved by this adjustment remained unclear.
Lucas et al. outlined the consequences of adjustment for adult weight (or length) 
in a multivariate regression analysis 73. They proposed using four regression models 
to analyse the data (Table 1), and stated that in the adjusted models the early and 
later size of the subjects can no longer be interpreted as stand- alone variables: 
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adjusting early size for later size is a measure of change in size between the earlier 
and later measurement. In their terminology the early model describes the relation 
between early size (i.e., birth weight, or bw) and outcome (Y = α1 + β1Xbw). In the 
late model, the relation between later size (i.e., adult weight, or aw) and outcome is 
studied (Y = α2 + γ2Xaw). The combined model (adding later size to the early model) 
can be interpreted as describing the relation between change in size and outcome 
(Y = α3 + β3Xbw + γ3Xaw), as argued by Lucas et al. (Table 1). Adding the interaction 
term of early and later size to the model yields the interaction model, allowing the 
exploration of whether early size affects the relation between later size and outcome 
(Y = α4 + β4Xbw + γ4Xaw + δ4XbwXaw).
73 Note, however, that the changing coefficients (in 
size and direction) in the combined and interaction models compared to the early 
model result in a complicated interpretation. Indeed, the effect of later size is co-de-
termined by the effect of early size on outcome, because adult weight is determined 
in part by birth weight, which influences the coefficients in the combined model. 
This also implicitly assumes a quadratic relation between birth weight and outcome 
in the interaction model, at least under the assumption that birth weight and adult 
weight are linearly related (Table 1).
Table 1: Interpretation of multivariate regression model by Lucas et al.73.
Early model: regression analysis of early weight (ew) to outcome measure 
Y = α1 + β1Xbw
Late model: regression analysis of adult weight (aw) to outcome measure 
Y = α2 + γ2Xaw
Combined model: adding later size to early model
Y = α3 + β3Xbw + γ3Xaw 
Interaction model: adding the interaction of early and adult size to the combined model. 
Y = α4 + β4Xbw + γ4Xaw + δ4(XbwXaw)
Interaction model with subtraction of the means:
Y = α4 + β4Xbw + γ4Xaw + δ4((Xbw-X
–
bw)( Xaw- X
–
aw))
Xbw = birth weight; Xaw = adult weight; XbwXaw = interaction of birth weight and adult weight; Y = expected outcome; α = 
intercept;  β, γ, δ = coefficient.
Which analysis meets the researcher’s concerns? 
Whether later size (e.g., adult weight) is a confounder in the analysis of early size 
(e.g., birth weight) and adult diseases, such as hypertension, or is rather a factor 
in the causal pathway is an ongoing debate in the literature. Adjustment for adult 
weight might not be justified after all 70-72. Whatever the causal explanation, birth 
weight is positively correlated with adult weight and adult weight is correlated with 
adult blood pressure; therefore, we do first of all expect that any positive relation 
between birth weight and adult blood pressure will be attenuated upon adding 
adult weight to the model (the coefficient of birth weight will become closer to 
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Table 2: Interpretation of unexplained residual regression model
Early model: regression analysis of early weight to outcome measure 
Y = α1 + β1Xbw
Late ‘unexplained residual’ model: regression analysis of residual of expected adult weight to outcome 
measure. First expected adult weight (eaw) is calculated: Xeaw = expected adult weight, based on birth 
weight (α0 + β0Xbw). Then, the residual for expected adult weight is calculated as: Xres= (Xaw – Xeaw) leading to
Y = α2 + γ2Xres
Combined ‘unexplained residual’ model: adding the residual of the expected adult weight to early 
model
Y = α3 + β3Xbw + γ3Xres
Interaction ‘unexplained residual’ model: adding the interaction the difference between birth weight 
and the mean birth weight and the difference between the residual and the mean residual of the expected 
later size to the ‘combined unexplained residual model’. 
Y = α4 + β4Xbw + γ4Xres + δ4((Xbw – X
–
bw)( Xres – X
–
res)) in which X
–
res is zero.
In this model β1 = β3 = β4 and γ2 = γ3 = γ4. 
Xbw = birth weight; Xres = residual of expected adult weight, based on birth weight; (Xbw – X
–
bw)( Xres – X–res)= interaction of 
birth weight and residual of expected adult weight; Y = expected outcome; α = intercept; β, γ, δ = coefficient
zero). Next, according to Lucas, it might be those who grew more than expected 
(i.e., attained greater adult weight for a given birth weight) who would develop the 
higher blood pressures. This would reverse the already attenuated relation with 
birth weight into a negative relation. 
As researchers, we remain interested in the separate contribution of birth weight 
(reflecting pre-birth influences) and change in weight from birth to adulthood (re-
flecting early life influences). Thus, we want to have an estimate of both. We want 
first an estimate of the effect of birth weight alone, and second, what we really want 
to know is the effect of someone growing more in weight than would be expected 
from a given birth weight. In a statistical analysis this can be accomplished in a 
single model by first calculating the expected adult weight, or eaw, based on birth 
weight (Xeaw = α0 + β0Xbw), and then subtract expected adult weight from actual adult 
weight – which is in effect the calculation of a residual (Xres = Xaw – Xeaw) (Table 2). 
Adding this residual increase in weight in a regression model of blood pressure on 
birth weight has three advantages. First of all it leaves the coefficient of birth weight 
unchanged (because the effect of birth weight on adult weight is already taken out 
of the residual). Second, it gives us an insight into the additional influence of grow-
ing more in weight than expected upon the adult blood pressure. Thirdly, the two 
variables in the regression model (birth weight and the residual increase in weight) 
are now independent, because the residual cannot be predicted from birth weight. 
Therefore, the interaction model does not assume a quadratic relation anymore. Li 
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et al. earlier described this model in the analyses of a Guatemalan study in which 
the association between prenatal and postnatal growth and adult body composi-
tion was studied 76; however, no algebraic explanation of this model was shown. 
The proposed technique is not unique to the problems of interpreting regression 
in the fetal origins to adult diseases hypothesis. It has been used in social sciences 
literature under the name of residualized gain score 77;78.
It should be noted that algebraically the combined model of Lucas et al. is the 
same as the combined model using unexplained residuals (Appendix A); however, 
the effect of birth weight and residual postnatal growth is directly shown by the 
coefficients of the proposed unexplained residual regression model. In both mod-
els, for the interaction model we suggest to multiply not just the two variables, 
but first subtract the mean of that variable. In the Lucas model this becomes 
(Xbw – X
–
bw)( Xaw - X
–
aw); in the proposed model this becomes (Xbw - X
–
bw)( Xres – X
–
res). As the 
mean of a residual is zero, this can be rewritten in (Xbw - X
–
bw) Xres. 
Next to the model of Lucas et al.. other simplified models are suggested to use 
in the fetal origins to adult diseases hypothesis analysis to measure the effect of 
change in weight. When researchers think about the problem they often intuitively 
propose to subtract adult weight (SDS) and birth weight (SDS) as a measure of 
change in weight and add this to birth weight (SDS) in a multivariate regression 
model. However, the problem with this model is the phenomenon of regression 
to the mean. The relative position of subjects with low birth weight will tend to 
increase and that of subjects with high birth weight will tend to decrease over time. 
This phenomenon is not present in de unexplained residual model, because in the 
calculation of adult weight residuals out of birth weight we force the residuals not 
to be related to birth weight. The coefficient of birth weight in a linear regression 
model of adult weight residuals is exactly zero (with very small confidence interval 
and a P-value of exactly 1).
Second, it has also been suggested to use population based SD scores instead 
of calculating the residual of expected adult weight (SDS). However, the subjects 
studied in research concerning the fetal origins to adult diseases hypothesis are 
mostly not comparable to the general population, because of an overrepresenta-
tion of the low birth weight subjects. Subjects with low birth weight have different 
growing patterns. Therefore, for most studies it is not recommended to use popu-
lation-based SD scores to calculate expected adult weight (SDS) and weight gain 
(SDS). In addition, it takes about three years after birth before an individual will track 
on his or hers centile, especially in low birth weight infants. If the population-based 
reference standards were to be used as a measure for expected adult weight (SDS), 
in which the mean adult weight (SDS) will be zero, low birth weight (SDS) subjects 
will tend to have a negative residual for adult weight, because of their suboptimal 
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growth. Then, the residual would not reflect the correct variable to answer our se-
cond question: what is the effect someone growing more in weight than would be 
expected from a given birth weight? So, calculating the residual adult weight out of 
birth weight should be performed with the expected adult weight from the group 
of subjects that are used in the study.
CONCLUSION, AND PROPOSAL
Algebraically, the combined model of Lucas et al. and our combined model with the 
residuals increase in weight can be rewritten in each other, except for the situation 
where an interaction term is entered (Appendix A). In the proposal by Lucas et al., 
however, one needs two separate models: first to estimate the coefficient from the 
early model, and then looking at the coefficient for attained weight in the com-
bined model (without paying attention to the coefficient of birth weight in that 
combined model, as the latter has become meaningless). For this reason, we prefer 
the proposed model with residuals because it permits in a more straightforward 
way to estimate the effect of birth weight and the effect of additional weight gain 
in a single model. We also prefer to use the interaction model containing the unex-
plained residuals, because no quadratic relation is assumed and because in prin-
ciple all coefficients show their own effect without mutual influence (see Table 2). 
Therefore, the interpretation of the model with the unexplained residuals is easier. 
An example with numerical data from an ongoing study in the Netherlands is given 
in Appendix B, including tables B1 and B2. 
In conclusion, we prefer to use regression model with unexplained residuals when 
the adjusted variable is in the causal pathway in the analyses of data referring to the 
fetal origins of adult diseases hypothesis. 
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APPENDIX A 
Derivations
To rewrite the combination unexplained residual model in the combined model by 
Lucas et al.73, where Y is the expected outcome; α is the intercept; β is a coefficient; 
Xbw is the birth weight; Xaw is the adult weight; Xeaw is the expected adult weight, 
based on early size (α0 + β0Xbw); and Xres is the residual of expected adult weight 
(Xaw – Xeaw)
Y= α1 + β1Xbw + γXres (the unexplained residual model)
Y= α1 + β1Xbw + γ(Xaw - (α0 + β0Xbw))
Y= α1 + β1Xbw + γXaw - γα0 - γβ0Xbw
Y= (α1 - γα0) + (β1- γβ0) Xbw + γXaw
Y= α’+ β’ Xbw + γ’Xaw (Lucas model)
α’ = α1 - γα0
β’ = β1 - γβ0
γ’ = γ
To add the interaction term ((Xbw – X
–
bw)*( Xaw-X
–
aw) into the Lucas model, first suppose 
that Xaw is exactly linearly related to Xbw. Then, where ε is the residual:
 Xaw = α0 + β0Xbw + ε (in which) 
and 
 X
–
 aw = α0 + β0 X
–
bw 
So, 
 (Xaw-X
–
aw) = (α0 + β0Xbw + ε) – (α0 + β0 X
–
bw) 
which can be rewritten as 
 (Xaw-X
–
aw) = β0 (Xbw – X
–
bw) + ε
Adding this to the interaction term (Xbw – X
–
bw)*( Xaw-X
–
aw), the equation becomes: 
 (Xbw – X
–
bw)*( β0 (Xbw – X
–
bw) + ε)
This can be rewritten as 
 β0 (Xbw – X
–
bw)
2 + (Xbw – X
–
bw) * ε
Here, the quadratic relation between birth weight and outcome is shown.
To add the interaction term into the unexplained residual model:
 (Xbw – X
–
bw)( Xres – X
–
res) = (Xbw – X
–
bw) Xres 
In this model Xres (the residual of expected adult weight) is independent of Xbw (birth 
weight). All coefficients show the (unadjusted) effect of the variable on outcome 
variable.
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APPENDIX B
Example of regression analysis according to Lucas and the unexplained residual 
model 73 (Tables B1 and B2): In a prospective study the systolic blood pressure at 
adult age was measured. Birth weight standard deviation scores (BW-sds) and adult 
weight standard deviation scores (AW-sds) were known.
Table B1: Estimated coefficients in our example when Lucas model is used, two types of interaction used.
Model Lucas α β γ δ
Xbw Xaw XbwXaw
Early 122.943 (α1) 0.361  (β1)
Late 123.908 (α2) 2.069 (γ2)
Combined 123.743 (α3) - 0.0928 (β3) 2.096 (γ3)
Interaction 123.771 (α4) - 0.0078 (β4) 2.231 (γ4) 0.120 (δ4)
Xbw Xaw (Xbw- X
–
bw)*
(Xaw- X
–
aw)
Interaction with 
subtracted means
123.710 (α4) - 0.0766 (β4) 2.125 (γ4) 0.120 (δ4)
α = intercept; β, γ, δ = coefficient; Xbw = birth weight (SDS); Xaw = adult weight (SDS)
Table B2: Estimated coefficients in our example when ‘unexplained residual model’ is used.
Model unexplained 
residuals
α β γ δ
Xbw Xres (Xbw- X
–
bw) Xres
Early 122.943 (α1) 0.361 (β1)
Late 123.623 (α2) 2.096 (γ2)
Combined 123.943 (α3) 0.361 (β3) 2.096 (γ3)
Interaction 123.943 (α4) 0.361 (β4) 2.121 (γ4) 0.102 (δ4)
α = intercept; β = coefficient; Xbw = birth weight (SDS); Xres = residual of expected adult weight (SDS); MeanXres equals zero in 
interaction term (Xbw- X
–
bw)( Xres - X
–
res). 
Expected adult weight (Xeaw) = - 0.382 + 0.216* Xbw. Residual of adult weight (Xres) = Xaw - Xeaw
In Table B1, the change in estimated coefficients is shown in both the combined 
as the interaction model, both with and without the subtractions of means, when 
the model of Lucas et al. is used.73 In the early model birth weight (SDS) is related to 
blood pressure with a coefficient of 0.361. When adult weight (SDS) is added to the 
model the coefficient for birth weight (SDS) changed into a negative one (-0.0928). 
This is a result of the relation between birth weigth (SDS) and adult weight (SDS). 
This change in the estimated coefficient is confusing for many authors; which co-
efficient is giving information about the relation between birth weight (SDS) and 
blood pressure?
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In the combined ‘unexplained residuals’ model these estimated coefficients do not 
change (Table B2) when adult weight (SDS) is added to the model. The coefficient 
for birth weight and residual weight gain shift slightly in the interaction model in 
comparison with the combined ‘weight residual model’: probably this is due to non-
exact-linear correlation between birth weight and weight gain. 
The δ4 coefficient does not change much in our example. The reason is that Xbw 
is not related to systolic blood pressure. Therefore, the δ4 coefficient in the Lucas 
model is comparable to the δ4 coefficient in our model. When Xbw would be qua-
dratically related to blood pressure, the δ4 coefficient would differ much in both 
models.

Chapter 3
POPS 19 study: Study design, blood pressure and renal function 

Chapter 3.1
Study design POPS 19 study 
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INTRODUCTION
Since the introduction of Neonatal Intensive Care Units in the sixties the chance of 
surviving very premature birth and (very) low birth weight has improved dramatic-
ly.79-81 Use of high quality techniques and medication not only led to a decrease in 
mortality rates, but also to an increased concern on long-term outcome.82 General 
health, neuromotoric and cognitive development, and behaviour have been shown 
impaired after very preterm or low birth weight birth.83-85 
PROJECT ON PREMATURES AND SMALL FOR GESTATIONAL AGE 
INFANTS (POPS)
A birth cohort of very preterm born infants (gestational age <32 weeks) and very low 
birth weight infants (birth weight < 1500 g) was recruited in 1983 in the Netherlands 
to obtain obstetric, perinatal, and neonatal parameters and evaluate survival and 
morbidity.86 Of all eligible neonates, 94% were included in this follow-up study 
(N=1338), which equals 0.7% of all births in the Netherlands in 1983 (Figure 1). Du-
ring follow-up, almost 30% of the included individuals died, mainly during the first 
year of life. Follow-up was assessed at 3, 6, 12, and 24 months corrected age and at 
the age of 5 years to obtain information on general health, growth and develop-
ment of these infants. Questionnaires on health, disabilities, school performance 
and quality of life were completed at the ages of 9, 10, and 14 years. 83 The majority 
(90%) of the individuals have survived without severe disabilities at school age, but 
many meet serious difficulties in everyday life. 
STUDY DESIGN POPS 19 STUDY
At the age of 19 years a new follow-up study of the POPS cohort was conducted to 
obtain information on general health, psychological and social aspects (POPS 19 
study). General health included parameters of Syndrome X (blood pressure mea-
surement, anthropometric measurements, ultrasound of carotic arteries to estimate 
Intima Media Thickness and laboratory diagnostic examination of blood and urine 
samples), neuromotoric examination, audiologic test, cognition test, pain coping 
test (Figure 2). Psychosocial parameters were obtained using several questionnaires, 
filled out by the participants and their parents (eg, Young Adult Self Report, Young 
Adult Behaviour CheckList, Health Utility Index, London Handicap Scale). 
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1983: GA < 32 weeks 
and / or BW < 1500 g 
N=1338
1997: Alive at 14 years 
N=962
Lost to follow up 
before 14 y  
N=28
2002: Asked to participate at 19 y 
N=934
Willing to participate 
N=705
No response 
N=56
Refused participation 
N=170
Only Questionnaires 
N=109
Outpatient Clinic Visit 
N=596
GA < 32 weeks 
N=422
GA � 32 weeks 
N=174
BW-sds < -2  
N=29 (SGA)
BW-sds > 0 and < 2 
N=205 (AGA)
POPS Nephrology study  
(2003-2004) 
Died between 14-19 y 
N=3
Rest 
N=188 
Figure 1: Flow chart inclusion of participants of the POPS 19 study (2002-2003)
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All individuals were recruited by mailings and phonecalls performed by TNO Qual-
ity of Life, Leiden, The Netherlands. All participants were invited to visit one of ten 
outpatient clinics for the follow-up visit between April 2002 and May 2003. At the 
age of 14 years, 962 individuals were alive, and 28 individuals were lost to follow 
up, leading to 934 individuals eligible for inclusion at the age of 19 years. (Figure 1) 
Eventually, 596 individuals participated in the POPS 19 follow-up study. 
All ten participating outpatient clinics were involved in a specific part of the 
POPS 19 study protocol. Parameters on Syndrome X were analysed in collaboration 
between the Erasmus MC – Sophia Children’s Hospital, University Medical Center 
Rotterdam, Department of Pediatric Nephrology and the Leiden University Medical 
Center, Department of Clinical Epidemiology and Department of Pediatrics.
Day 1
Morning urine collection
10.00 p.m. start 24-hour urine collection
Day 2
10.00 p.m. finish 24-hour urine collection
Day 3
Morning urine collection
Programme day 3
Figure 2A: Urine collection
8.00-9.00
Informed consent procedure
Questionnaire 1
Interview
9.00-10.00
BP measurement after 30 minutes of rest 
Venapuncture (Creatinine, urea, Na, K, PRA.)
Breakfast 
Questionnaire 2 
10.00-11.00
Neuromotoric examination 
Anthropometrical examination 
Audiometric examination 
11.00-12.00
Cold Pressor Test (Pain coping test)
IMT measurement by carotic ultrasound 
12.00-13.00 Cognition test
13.00-14.00 Evaluation
Figure 2B: Programme day 3 
Figure 2: Time line POPS 19 study
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DATA OBTAINMENT
In this thesis only parameters on blood pressure and renal function estimation are 
described in detail.
Blood pressure measurement
SBP and diastolic BP were obtained with an automatic BP device (Dinamap). Three 
measurements were performed at the nondominant arm in supine position after 30 
minutes of rest in the same position. The cuff size was adjusted for arm length and 
circumference. Mean values were used in statistical analysis. Mean arterial pressure 
(MAP) was calculated [(SBP + 2 * DBP) / 3]. Information about medical history and 
drug use was obtained by an interview. 
Renal function
Microalbuminuria Two morning urines were obtained at two different days prior to 
the visit. Albumin to creatinine ratio (ACR: mg/mmol) was measured in both urine 
samples. If the mean of two ACR values was higher as 2.2 mg/mmol, the subject was 
considered as microalbuminuric.87 When only one morning urine was obtained, that 
result was used.
Glomerular filtration rate GFR was estimated with the Cockcroft-Gault equation 
adjusted for body surface area (ml/min/1,73m2), and with the simplified MDRD 
equation.88;89 
Laboratory assays
Sodium, potassium, creatinine, and urea were measured in a fully automated com-
puterized laboratory system with a Hitachi 747 (Hitachi, Tokyo, Japan) chemistry 
analyzer. Plasma renin activity (PRA) was measured by quantification of the gener-
ated Angiotensin I with a radioimmunoassay (Incstar, Stillwater, MN 55082, USA). 
The sensitivity was 0.05 μg/l per hour and the coefficients of variation ranged from 
5.6 to 7.6 % at different levels. Microalbumin was measured with a turbidimetric 
assay on a Hitachi 911 (Hitachi, Tokyo, Japan).
INFORMED CONSENT AND ETHICS COMMITTEE
Informed consent was obtained after oral and written information had been given. 
The ethics committees of all participating centers approved the study protocol.
Chapter 3.2
Is BP increased 19 years after intrauterine growth retardation and 
preterm birth? A prospective follow-up study in the Netherlands
MG Keijzer-Veen, MJJ Finken, J Nauta, FW Dekker, ETM Hille, M Frölich, JM Wit, 
AJ van der Heijden, on behalf of the Dutch POPS-19 Collaborative Study Grou
Pediatrics 2005;116(3):725-731.
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ABSTRACT
Objective: To determine whether intrauterine growth retardation (IUGR) is a predis-
posing factor for high BP in 19-year-olds, born (very) preterm.
Methods: A prospective follow up study was conducted at age 19 in individuals 
who were born preterm in the Netherlands in 1983. Systolic, diastolic and mean BP 
values and plasma renin activity concentration were obtained in 422 young adults 
born with a gestational age (GA) < 32 weeks. BP values were also measured in 174 
individuals who were born with a GA ≥ 32 weeks and a birth weight < 1500 gram. 
Results: An increased prevalence of hypertension and probably also of prehyper-
tensive stage was found. IUGR, birth weight, GA and plasma renin activity were not 
associated with BP. Current weight and BMI were the best predicting factors for 
systolic BP at the age of 19 years.
Conclusions: The prevalence of hypertension is high in individuals who were born 
preterm when compared with the general population. In the individuals who were 
born very preterm born, no support to the hypothesis that low birth weight is as-
sociated with increased BP at young adult age can be given. 
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INTRODUCTION
The suggested association between birth weight and adult diseases was studied in 
many epidemiological studies in the past decades (‘fetal origins of adult diseases’ 
hypothesis).90;91 In these studies, an inverse relation has been described between 
birth weight and hypertension, hyperlipidemia, type II diabetes, and cardiovascular 
diseases in adult life. Individuals born after intrauterine growth retardation (IUGR) 
are thought to be at risk for developing high BP (BP) compared with subjects with 
the same birth weight but no IUGR.3;92
Besides low birth weight, three other early factors that are considered to be 
important risk factors for developing high BP in adult life have been identified in 
individuals with IUGR. First, accelerated postnatal growth in weight and length are 
suggested to increase the risk for developing hypertension and type II diabetes in 
later life, especially in low birth weight individuals.4;15;16
Second, it was postulated that altered angiotensin activity was an important 
factor underlying the ‘fetal origins of adult diseases’ hypothesis.58;59 Also, hypoxia 
increased sympatic nerve activity and catecholamine production and proliferation 
of juxta-glomerular cells (and thus renin-producing cells) are suggested as factors 
in the pathogenesis. 
Finally, preterm infants are probably at even greater risk of developing adult dis-
eases compared with individuals who were born at term. A large Swedish study 
showed an inverse association between gestational age (GA), ranging from 35 - 44 
weeks, and systolic BP (SBP) in 165,136 Swedish men.5 This correlation may be stron-
ger in the lower range of gestation (GA 30-38 weeks), as demonstrated by Siewert-
Delle et al.65 Very preterm infants who born with a GA <30 weeks were not included 
in this study. In contrast, other studies do not support these data. Singhal et al. did 
not find an attributable risk to vascular disease at the age of 15 years in 216 preterm 
individuals (mean GA: 31 weeks) compared with individuals who were of the same 
age and born at term.69
It is suggested that the underlying mechanism for prematurity influencing BP 
and cardiovascular risk is related to an impaired (fetal) organ development. Many 
organ systems, such as kidneys and pancreas, develop until the third trimester of 
normal pregnancy. Preterm birth requires an increased energy of the neonate to 
grow and survive. Organ development, such as nephrogenesis and β-cell develop-
ment in the pancreas, is probably not or only partly completed after preterm birth.63 
Large studies that include the lowest ranges of gestation are needed to explore the 
role of prematurity and growth retardation with respect to the ‘fetal origins of adult 
disease’ hypothesis.
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Also, several maternal factors, such as maternal hypertension, smoking during 
pregnancy, and perinatal and postnatal factors such as Apgar score and co-mor-
bidity after birth and drug use, are supposed to influence both neonatal and adult 
health. To our knowledge, no previous prospective studies were able to analyse 
these potential confounders in the relation to birth weight and BP.
In this article, we describe the results of a large, prospective, follow-up study in 
which BP was obtained in 19-year-olds who were born in 1983 with a GA <32 weeks. 
Within this cohort our objective was (1) to determine whether IUGR is associated 
with increased BP at age 19 after very preterm birth and whether this is amplified 
as a result of accelerated weight gain and growth postnatally and (2) to determine 
whether IUGR is associated with alterations in renin concentrations at age 19 after 
very preterm birth. In addition, the effects of potential maternal, perinatal and post-
natal confounders on BP at young adult age were studied, as well as the relation 
between GA and BP.
METHODS
Study population
Participants were recruited from the POPS cohort (Project On Prematures and Small 
for gestational age infants). The POPS cohort comprises of 94% of all Dutch neo-
nates (n=1338), who were born alive in 1983 with a GA <32 weeks (group 1) and / or 
a birth weight < 1500 gram (group 2).86 All individuals who were alive at the age of 
19 years (n=959) and not lost to follow-up until the age of 14 y (n=934) were invited 
to participate in a prospective follow-up study conducted from April 2002 until May 
2003 in ten outpatient clinics in the Netherlands. 
Perinatal parameters (eg, birth weight, GA, Apgar score, congenital anomalies) 
and obstetric parameters (eg, maternal hypertension, medication during pregnan-
cy, smoking during pregnancy) were known since birth. Follow-up data for growth 
(height, weight and body mass index) until the age of 10 years were also known in 
almost all subjects.
Birth weight and birth length were converted to standard deviation scores (BW-
sds and BL-sds respectively), using Swedish reference standards.93 BW-sds was con-
sidered as a measure of IUGR. At follow-up visits at the ages 3, 6, and 12 months 
weight and length (measured in supine position) and at the ages of 2, 5, 10 and 19 
years data on weight and height (measured in standing position) were recorded. All 
weight, length and height values were recorded with standardized scales and were 
expressed as SDS using Dutch reference standards.94 BMI was calculated as weight 
(kg) / length or height (m)2 and converted to SDSs as well for all follow-up ages. 
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The main statistical analyses included only participants of group 1 (GA < 32 
weeks). To study the relation between GA and BP, also participants of group 2 (GA 
> 32 weeks and birth weight < 1500 gram) were included to increase the range of 
gestation until 40 weeks. Prevalence rates of hypertension were also calculated in 
both groups.
Data obtainment
SBP and diastolic BP were obtained with an automatic BP device (Dinamap). Three 
measurements were performed at the nondominant arm in supine position after 30 
minutes of rest in the same position. The cuff size was adjusted for arm length and 
circumference. Mean values were used in statistical analysis. Mean arterial pressure 
(MAP) was calculated [(SBP + 2 * DBP) / 3]. Information about medical history and 
drug use was obtained by an interview. 
Individuals were excluded from the analyses when antihypertensive medication 
was used, individuals were pregnant, or BP was not measured according protocol. 
Weight and height were recorded to the nearest 0.1 kg and 0.1 cm, respectively, 
using calibrated scales. Participants were categorized into normal BP (SBP < 120 
mmHg and DBP < 80 mmHg), prehypertensive BP (SBP 120-139 mmHg or DBP 80-89 
mmHg), hypertension stage 1 (SBP 140-159 mmHg or DBP 90-99 mmHg) or hyper-
tension stage 2 (SBP > 160 or DBP > 100mmHg) according the JNC VII criteria.95
A blood sample was obtained after BP measurement, in which plasma renin ac-
tivity (PRA) was measured by quantification of the generated Angiotensin I with 
a radioimmunoassay (Incstar, Stillwater, MN 55082, USA). The sensitivity was 0.05 
μg/l per hour and the coefficients of variation ranged from 5.6 to 7.6 % at different 
levels.
Informed Consent and Ethics Committee
Informed consent was obtained after oral and written information had been given. 
The ethics committees of all participating centers approved the study protocol.
Statistics
Student’s unpaired t tests were performed to compare BP means. Because birth 
weight is positively associated with adult weight, and adult weight influences BP 
(causal pathway)96, we used a multivariate regression model to analyze the effect of 
birth weight on BP and the effect of growing more in weight than would be expected 
from a given birth weight. Therefore, we first used linear regression to calculate the 
expected adult weight (or weight at 3, 6, 12, 24 months and 5 or 10 years), based on 
birth weight, and then subtracted the actual adult weight (or weight at the age of 
3, 6, 12 months and 2, 5, 10 or 19 years). This ‘residual’ was entered in the final linear 
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regression model.76 Recently, we explained the algebraic concept of this regression 
model.97 The coefficient of BW-sds shows the effect of BW-sds on adult BP, and the 
coefficient of the ‘residual adult weight’ shows the effect of gaining more weight 
than expected’ on adult BP. Equally, multiple logistic regression analyses were ap-
plied to evaluate the effect of BW-sds and residual weight and height adjusted for 
gender on the prevalence of hypertension. The effect of GA and gender on BP and 
the prevalence of hypertension was analyzed separately with linear and logistic re-
gression models. Statistical significance was defined at p-value < 0.05.
RESULTS
Subject characteristics
Of 934 eligible individuals, 596 subjects participated in this study (response 63.8%). 
Of the 338 nonresponders, 59 were lost to follow-up, 53 were not able, 177 did not 
feel like, and 27 did not have time to participate. Thirteen individuals could not be 
included within the research period and in 9 individuals the reason for nonresponse 
is unknown. 
Five individuals mentioned that they had had increased BP in the past, but none 
were treated for hypertension at the time of the study. Eight individuals were ex-
cluded from data analysis: 4 because of use of antihypertensive medication for 
other reasons than hypertension (eg, restless legs and nervousness), 2 because of 
protocol violation, 1 subject because of pregnancy, and 1 because of unreliable BP 
measurement. Therefore, SBP and DBP data of 588 subjects were analyzed, 264 of 
whom were male and 324 of whom were female (Table 1). The mean age was 19.29 
(range 18.63 -20.18) years. A total of 418 participants were born with a GA < 32 
weeks (group 1); 170 were born with a GA ≥ 32 weeks and with a birth weight < 
1500 grams (group 2). GA and birth weight of the participants in group 1 were 29.7 
± 1.53 weeks and 1314 ±338 g and in group 2 33.9 ± 1.63 weeks and 1274 ± 177 g, 
respectively. 
Of all individuals who were alive at 19 years, birth weight and GA did not dif-
fer between the responders and nonresponders (mean difference for birth weight: 
23 g (95%CI:-12;59 g); mean difference for GA: 0.2 week (95%CI:-0.1;0.5)). Baseline 
characteristics of the nonresponders are shown in table 1. Compared with the indi-
viduals in the original cohort (including those who died and were lost to follow-up), 
the responders had a higher mean birth weight (101 g; 95% CI of mean difference: 
67;134 g) and a longer duration of GA (1.2 weeks; 95% CI of mean difference: 0.9;1.5 
weeks). 
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BP values
Data of BP values are shown in table 1. The mean (± SD) SBP, DBP and MAP in sub-
jects in group 1 was 123 ± 13 mmHg, 66 ± 8 mmHg, and 85 ± 9 mmHg, respectively. 
Subjects in group 2 had a mean SBP, DBP, MAP of 122 ± 12 mmHg, 66 ± 8 mmHg, and 
85 ± 8 mmHg, respectively. SBP was higher in men (126 ± 12 mmHg) than in women 
(120 ± 12 mmHg). DBP was lower in men (64 ± 8 mmHg) than in women (68 ± 8 
mmHg). Prenatal (maternal hypertension and maternal smoking during pregnancy) 
and perinatal and postnatal parameters (alterations on cardiotocographic measure-
ment, Apgar score, neonatal use of corticosteroids, sepsis and infant respiratory 
distress syndrome status) all were related to BW-sds but not to SBP and DBP values 
(data not shown). Therefore, no adjustment for these parameters was required. 
In a linear regression analysis of participants who were born with a gestational 
age < 32 weeks, BP was not associated with birth weight, BW-sds, birth length, and 
BL-sds, all adjusted for gender. Regression coefficients (β values) are given in Tables 
2 and 3. Increased postnatal weight gain and BMI after the age of 5 years both were 
predictors for SBP at the age of 19 years. The strength of this relation increased with 
age. Height at 5 years of age predicted SBP, DBP and MAP at age 19. However, the 
actual effect on both SBP and DBP was very small (0.3 mmHg increase in SBP per 
1 SD more increase in height than expected at age 5). Current weight (SDS) and 
current BMI (SDS) were the strongest predictors for SBP (β = 2.3 mmHg/ 1 residual 
weight SDS and 2.4 mmHg / 1 residual BMI SDS, respectively). Early postnatal weight 
gain (0-2 y) and increase in length were not related to BP at the age of 19 years. 
BP was also not related to GA, both when only participants in group 1 were in-
cluded (β for SBP: -0.251 mmHg / week increase in GA; 95%CI: -1.016;0.514) and 
when all participants were included (β for SBP: -0.149 mmHg / week increase in GA; 
95%CI:-0.542;0.245), or when only subjects with a birth weight < 1500 gram were 
included (β for SBP: -0.150 mmHg / week increase in GA; 95%CI: -0.553;0.254).
Table 1: Patient characteristics and Baseline characteristics of non-responders.
All subjects: N=588
< 32 weeks and/or 
< 1500 gram
Group 1: N=418
< 32 weeks
Group 2: N=170
≥ 32 weeks and 
< 1500 gram
Non responders
N=363
Men, % 44.9 46.7 41.4 62.8
Birth weight, g 1303 ± 302 1314 ± 338 1274 ± 177 1328 ± 251
GA, wk 30.9 ± 2.5 29.7 ± 1.5 33.9 ± 1.6 31.2 ± 2.6
Age, y 19.3 ± 0.2 19.3 ± 0.2 19.3 ± 0.2
SBP, mmHg 123 ± 12 123 ± 13 122 ± 12
DBP, mmHg 66 ± 8 66 ± 8 66 ± 8
MAP, mmHg 85 ± 9 85 ± 9 85 ± 8
Data expressed by mean ± SD.
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PRA was inversely related to BP adjusted for gender (β for SBP: -0.022 mmHg / 
1 μg/l per hour (95%CI: -0.032;-0.011, p-value 0.001); β for DBP: -0.013 mmHg / 1 
μg/l per hour (95%CI: - 0.037;-0.005, p-value 0.011); β for MAP: -0.024 mmHg / 1 
μg/l per hour (95%CI: -0.039;-0.009, p-value 0.002). Regression coefficients were not 
different between participants with low and high BW-sds. PRA was not related with 
BW-sds or GA (Table 4 for mean values within BW-sds tertiles).
The prevalence of hypertension (SBP > 140 mmHg or DBP > 90 mmHg) was 10.5% 
and of prehypertensive stage was 45.9% (SBP 120-139 mmHg or DBP 80-89 mmHg) 
within group 1 and 8.8% and 37.6% respectively within group 2 (Table 5). The crude 
risk for hypertension was higher in men (odds ratio: 2.7; 95%CI 1.4;5.3) compared 
to women (logistic regression). BW-sds and GA both did not affect the risk for hy-
pertension. Increased postnatal weight gain and BMI after 5 years were predictors 
for the risk for hypertension at the age of 19 years, but current weight (19 years) 
affected the risk the most.
DISCUSSION
This article describes the results of the first large scale prospective study on the sug-
gested association between IUGR and BP at the age of 19 years, in individuals who 
were born with a GA < 32 weeks and/or a birth weight < 1500 grams. Our main find-
ing was that we were not able to show a relation between BW-sds, BL-sds, or GA and 
adult BP. Adjustment for height, a common procedure in pediatric BP interpretation, 
did not reveal a relation between BW-sds and BP either. Also accelerated postnatal 
growth or weight gain during the first months in life (postnatal hypothesis) did not 
influence BP at the age of 19 years. Current weight and BMI were the best predictors 
for BP at age 19. 
A remarkable finding was that in our 19-year-old cohort (group 1), the mean SBP 
was high. In our cohort (mainly white), the SBP in men was 126 mmHg and 120 
mmHg in women. In comparison, the SBP of subjects of the same age (18-19 years) 
participating in the Bogalusa heart study was 115 mmHg in white men and 109 
mmHg in white women.98 The Third National Health and Nutrition Examination Sur-
vey (NHANES III) study reported a mean SBP in 17-year-olds of 117 mmHg in white 
boys and 107 mmHg in white girls.99 So, both in men and women, SBP was higher 
in our cohort. Other studies, like NHANES and Framingham heart studies, reported 
mean BP values in larger age categories (29-37 and 18-39 years), making compari-
son with our results difficult.100 
The prevalence of hypertension in our study was 10.5%. The overall prevalence 
of hypertension in individuals between 18 and 39 years of age was 7.2% in the 
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NHANES III survey.100 Moreover, as it has been reported that the prevalence of hy-
pertension increases by 1.3% with a 1-year increase of age,100 the prevalence of hy-
pertension in the general population between ages 18 and 39 would be higher than 
the prevalence in 19-year-olds. The prevalence of prehypertension in our cohort 
was 45.9%. Such individuals are suggested to have a twofold risk for progression 
towards hypertension in later life.95 Therefore, monitoring of BP in these subjects 
is recommended. However, whether the prevalence of prehypertensive stage 
(45.9% in our cohort) was also high compared with the general population and/or 
to a random 19-year old reference group is not known. Population based reports 
on BP prevalences according to the most recent criteria are needed. To compare 
our data with the Muscatine study we needed to categorize our data according the 
JNCV criteria.101 Then, the prevalence of normal BP (SBP < 130 mmHg and DBP < 85 
mmHg) in our cohort was lower compared with the subjects in the Muscatine study 
(62.4% versus 72%) and the prevalence of high BP (SBP 130-139 mmHg or DBP 85-
89) and hypertension stage I (SBP 140-159 mmHg or DBP 90-99) was higher (22.2% 
and 15.5% in our cohort versus 18% and 9% in the Muscatine study, respectively) in 
Table 4: Mean (SD) of BP values, PRA concentrations and BMI (SDS) within tertiles of birth weight (BW-sds) in participants of 
group 1.
Subjects group 1: 
(N=418)
Lowest tertile BW-sds 
(lowest thru –0.3814)
Middle tertile BW-sds 
(-0.3814 thru 0.3787)
Highest tertile BW-sds
(0.3787 thru highest)
ANOVA 
P-value
SBP, mmHg 122 (13) 123 (12) 124 (13) 0.731
DBP, mmHg 66 (8) 66 (8) 66 (8) 0.914
MAP, mmHg 85 (9) 85 (8) 85 (9) 0.951
PRA, μg/l per hour 2.5 (1.3) 2.2 (1) 2.3 (1.5) 0.331
BMI, SDS -0.3 (1.3) -0.2 (1.4) 0 (1.1) 0.074
SBP: Systolic BP, DBP: Diastolic BP, MAP: Mean arterial pressure. PRA: plasma renin activity.
Table 5: Prevalence of hypertension for all participants using the BP (BP) criteria according to the JNC VII.95
All subjects Group 1: < 32 weeks Group 2: ≥ 32 weeks and
< 1500 gram
N (%) N (%) N (%)
Normal BP * 273 (46.4) 182 (43.5)  91 (53.5)
Prehypertensive stage † 256 (43.5) 192 (45.9) 64 (37.6)
Hypertension stage 1‡ 55 (9.4) 42 (10.0) 13 (7.6)
Hypertension stage 2§ 4 (0.7) 2 (0.5) 2 (1.2)
Total 588 100.0) 418 (100.0) 170 (100.0)
* Normal BP: SBP < 120 mmHg and DBP < 80 mmHg.
† Prehypertensive stage: SBP 120-139 mmHg or DBP 80-89 mmHg.
‡ Hypertension stage 1: SBP 140-159 mmHg or DBP 90-99 mmHg.
§ Hypertension stage 2: SBP >160 mmHg or DBP >100 mmHg.
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both men and women.102 Again, the mean age of the participants in our cohort was 
much lower (19 years in our study versus 29-37 years in the Muscatine study). 
Several factors may have influenced our results. First, our protocol of BP measure-
ments to minimize variability deviated from other studies. We measured BP three 
times in rest, in supine position, and at the nondominant arm. BP values are sug-
gested to be lower when measured in supine position, but when the arm is sup-
ported at the heart level (which is the case in supine position) no significant error 
is expected.103
Second, our BP values may have been influenced because of the use of automatic 
ossilometric device (Dinamap). Two studies comparing manometric and Dinamap 
BP measurements reported an underestimation of the DBP values between 2.4 and 
8.2 mmHg when this automatic device was used.104;105 However, inconsistency on 
the SBP values exists. Coppieters et al. reported that SBP was systematically 3.6 
mmHg lower in Dinamap measurements, but Pavlik et al. reported a systematic 
overestimation of SBP between 1.0-6.7 mmHg when the Dinamap was used.104;105 
When we adjust for the systematic error as reported by Coppieters the prevalence 
of hypertension increased to 18.9% and the prevalence of prehypertensive stage 
to 48.5%. When the Dinamap systematically overestimated the SBP with 6.7 mmHg 
and underestimated DBP with 2.4 mmHg 104;105 the mean BP in our cohort decreased 
to 120 ± 12 mmHg for SBP and 67 ± 8 mmHg for DBP in men and 114 ± 12 mmHg 
for SBP and 70 ± 8 mmHg for DBP in women (data not shown). The prevalence of hy-
pertension within group 1 dropped to 4.3% and of pre-hypertensive stage to 31.8%. 
Still, mean SBP and DBP were higher compared with the subjects in the NHANES III 
and Bogalusa heart study.99;106
Third, it is recommended that BP be measured at least two times independently 
before the mean SBP and DBP are calculated a person is defined hypertensive. Our 
three BP measurements were performed at one day, and are evidently not inde-
pendent. However, the reference data we used to compare prevalence rates and 
mean BP values were also based on one initial screening and the mean of at least 
three measurements.99;100 Therefore, our data are comparable, showing both high 
prevalence and high mean BP. 
Our study indicates that individuals who were born very preterm have elevated 
mean BP values and that the prevalence of hypertension is increased at the age 
of 19 years. This is not related to the extent of IUGR (BW-sds), birth weight (g), or 
GA. In our cohort the range of birth weight is 560 to 2580 g. Most studies in which 
the relation between birth weight and adult BP was found included subjects with 
a birth weight ranging between 2000 and 5000 g.107-109 This suggests that the rela-
tion among birth weight, prematurity and BP may be diminished in the lower birth 
weight ranges or GAs, and is not a continuously linear but a curved dose-response 
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relationship. This would explain the increased mean BP values, increased preva-
lence of hypertension, and the absence of the relation between BW-sds and BP in 
the participants of group 1 in our cohort. This trend has not been described in other 
studies that included preterm individuals who were born at GA of 30 weeks. Future 
studies may help to confirm our findings. 
A few other reasons can account for the absence of the association between IUGR 
and BP. First, at 19 years of age, our cohort may have been too young to detect a re-
lation. Possibly, the differences were not present at this age yet, or differences were 
too small to detect with our tools (which measure BP 1-2 mmHg accurate). However, 
changes in BP as a results of IUGR have been shown in other studies at even younger 
age.110 Law et al described that the effect of low birth weight on BP may be obscured 
during adolescence.12;111 Follow-up of our subjects is therefore recommended.
Second, a selection bias could have been introduced because of a response of 
64%. Of all participants who were alive at age 19, no differences in baseline char-
acteristics were present. However, compared to the original cohort the responders 
had a slightly higher birth weight and were born after a longer duration of gestation 
compared with the non-responders. So those subjects with the suggested highest 
risk for increased BP were less included in the study, possibly leading to negative 
results. Even if this bias was introduced and a relation between IUGR and BP was 
concealed, our results concerning mean BP values and prevalence rates are prob-
ably underestimated, and conclusions would not change much. 
Finally, it is possible that the relation between birth weight and BP does not exist 
at all, and therefore was not found in our cohort. Indeed, authors have debated on 
contradictory results in several studies. Huxley et al. state that most studies that 
found a relation between birth weight and adult BP included small numbers of sub-
jects.72 With increasing study size the relation diminished, suggesting an publication 
bias.112 Furthermore, most studies failed to account for possible appropriate adjust-
ment for potential confounders, like current weight.72 As birth weight is positively 
correlated with current weight and current weight with BP, also in our cohort, cur-
rent weight cannot be designated as a potential confounder (causal pathway).70-72 
Therefore, we studied the effect of birth weight and current weight separately, using 
a multivariate regression model using ‘unexplained residuals’ for current weight as 
adjusting variable.76 Using this model no relation could be found.
Several authors suggested that other prenatal, perinatal and postnatal parameters 
could influence the association of birth weight and BP.71;72 In our study we were able 
to show that maternal hypertension, smoking during pregnancy, neonatal cortico-
steroids use, presence of infant respiratory distress syndrome, and alterations on 
cardiotocographic measurement were associated with BW-sds. All of these factors 
52
C
ha
pt
er
 3
.2
were not associated with BP at 19 years. We therefore conclude that these param-
eters are no confounders in our study.
As expected, PRA was negatively correlated to BP. Individuals with high levels of 
active renin will have lower BP values. However, neither BW-sds nor GA was associ-
ated to PRA. These data are not in agreement with the findings of Martyn et al,59 who 
showed increased plasma concentrations of (in)active renin at adult age in subjects 
who were large at birth. Konje et al found that active renin concentrations in the 
umbilical vein in neonates after delivery was higher in individuals who were small 
for gestational age.58 Both authors concluded that the renin-angiotensin system is 
altered in individuals with IUGR. Possibly, the relation between birth weight and 
PRA in our cohort is not found because the relation between birth weight and BP 
is not present. Contribution to the pathophysiological mechanism of the RAS can 
therefore not be given. 
CONCLUSIONS
In this large ex-preterm cohort, the mean SBP and the prevalence of hypertension 
were high. No relation with IUGR was found. Therefore, in individuals who were born 
prematurely, no support for the ‘fetal origins of adult diseases’ hypothesis can be 
given. Whether the relation between birth weight and BP is a curved dose-response 
curve needs to be studied, using subjects in all birth weight ranges, gestational 
ages and sophisticated BP tools. 
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Chapter 3.3
Microalbuminuria and lower glomerular fi ltration rate at young 
adult age in subjects born very premature and after intrauterine 
growth retardation
MG Keijzer-Veen, M Schrevel, MJJ Finken, FW Dekker, J Nauta, ETM Hille, M Frölich,
AJ van der Heijden, on behalf of the Dutch POPS -19 Collaborative Study Group
J Am Soc Neprhol 2005;16;2762-2768.

Renal function in POPS 19 study 57
ABSTRACT
This prospective follow up study in 422 19-year-old subjects born very preterm in 
the Netherlands was performed to determine whether intrauterine growth retar-
dation (IUGR) predisposes to abnormal glomerular filtration rate (GFR) and micro-
albuminuria in adolescents. GFR (ml/min/1.73m2) was estimated, using the Cock-
croft-Gault equation, and albumin-creatinine ratio (mg/mmol) was calculated in a 
cohort of 19-year-old subjects born very preterm (gestational age < 32 weeks) in 
1983. Birth weights were adjusted for gestational age and expressed as standard 
deviation scores (sds) as a measure of IUGR. All subjects had normal renal func-
tion. Birth weight (sds) was associated negatively serum creatinine concentration 
(μmol/l) (β = -1.0 μmol/l, 95%CI: -1.9; -0.2), positively with GFR (ml/min/1.73m2) (β 
= 3.0, 95%CI: 1.7; 4.2) and negatively with the logarithm of albumin-creatinine ratio 
(log mg/mmol) (β= -0.05, 95%CI: -0.09; -0.01) in young adults born very preterm. 
IUGR is associated with unfavourable renal functions at young adult age in subjects 
born very premature. These data suggest that intrauterine growth retarded subjects 
born very premature have an increased risk to develop progressive renal failure in 
later life.
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INTRODUCTION
Fetal kidney development is known to be impaired in subjects liable to intrauter-
ine growth retardation. In both animal and human studies it was shown that neo-
natal kidney volume and nephron number is reduced when intrauterine growth 
was impaired.44;46;113-115 Offspring of Spangue-Dawley rats, who were kept on a low 
protein diet during pregnancy, had a 28-29% decreased number of glomeruli in 
proportionally smaller kidneys.116 Also blood pressure was increased 8 weeks after 
birth. Mañalich described less glomeruli in the renal cortex per 0.6 mm2 in low birth 
weight neonates who died within 2 weeks after birth due to diseases not involving 
the kidneys.117 In this study there was a direct relation found between birth weight 
and number of glomeruli.
It has been suggested that low birth weight and impaired nephron number at 
birth increases the risk to renal failure and end stage renal disease in later life.17;18 
Brenner et al. suggested that the filtration surface area in kidneys with low nephron 
number is decreased compared to healthy subjects with normal nephron number. 
This decrease in filtration surface area would lead to glomerular and systemic hy-
pertension, glomerular damage and sclerosis and therefore to a decrease in renal 
function (‘hyperfiltration theory’).41 One of the first symptoms of developing renal 
disease is microalbuminuria followed by decrease in glomerular filtration rate. 
Recently, data have been published showing a strong relation between birth 
weight and renal size, nephron number, glomerular volume, albuminuria and sys-
tolic blood pressure in Aboriginal communities.34;45 In communities of aboriginals 
and Indians diseases like type II diabetes, cardiovascular diseases and renal diseases 
take epidemic proportions.42;43 Poverty and poor living conditions leading to low 
birth weight in the offspring are suggested to be important in the development of 
these diseases.118
It has been shown that preterm born subjects have smaller kidneys than subjects 
born at term. As nephrogenesis continues until 36 weeks of gestation, subjects 
born very prematurely are suggested to have less glomeruli than subjects born less 
preterm at birth. Recently, it was also shown that nephrogenesis ceases after very 
preterm birth.63 
The combination of prematurity and intrauterine growth retardation, which often 
are both present, might increase the risk for progressive renal failure even more. 
Data on renal function at adult age in subjects born very preterm is very scarce. 
We describe the results of a large-scale prospective follow-up study in subjects 
born with a gestational age < 32 weeks in 1983 in the Netherlands, in which we 
estimated glomerular filtration rate and measured microalbuminuria at the age of 
19 years. The objective was to evaluate the effect of intrauterine growth retarda-
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tion in these preterm subjects on renal function at young adult age. In addition, we 
evaluated the effect of gestational age, in the lowest ranges of gestation, on renal 
function at young adult age.
METHODS
Study population
In a prospective follow-up study carried out from April 2002 until May 2003 all 
survivors of the POPS cohort (Project On Prematures and Small for gestational 
age infants) born with a gestational age < 32 weeks were invited to visit one of 
ten outpatient clinics in the Netherlands, at the age of 19 years. The POPS cohort 
was recruited in 1983, where 94% of all Dutch neonates, born alive with a gesta-
tional age (GA) < 32 weeks and / or a birth weight (BW) < 1500 gram were included 
(n=1338).86 All subjects alive at the age of 19 years (n=959) and not lost to follow 
up (n=25) were invited to participate in a prospective follow-up study. For this part 
of the study only subjects born with a gestational age < 32 weeks (n=676) were 
eligible to participate. 
Data obtainment
Two morning urine samples were collected to measure creatinine and microalbu-
min concentrations to calculate albumin-creatinine ratio (ACR). Female subjects 
within their menstrual period at time of urine collection were excluded from the 
analyses of ACR. A blood sample was obtained to measure creatinine, urea, sodium 
and potassium concentrations.
Glomerular filtration rate (GFR) was calculated both with the Cockcroft-Gault 
equation, and adjusted for body surface area (ml/min/1,73m2), and with the sim-
plified MDRD equation.88;89 ACR (mg/mmol) was calculated in morning urines as 
a measure of microalbuminuria (<2.2 normal; 2.2-22.6: microalbuminuria; > 22.6 
macroalbuminuria or proteinuria).87 The average ACR in two morning urines was 
calculated and used in the analyses. When only one morning urine was obtained, 
that result was used. 
Sodium, potassium, creatinine, and urea were measured in a fully automated 
computerized laboratory system with a Hitachi 747 (Hitachi, Tokyo, Japan) chem-
istry analyzer. Microalbumin was measured with a turbidimetric assay on a Hitachi 
911 (Hitachi, Tokyo, Japan).
Perinatal parameters (like BW, GA, Apgar score) and obstetric parameters (like 
maternal hypertension, use of medication during pregnancy, smoking during preg-
nancy) were derived from the original POPS database (TNO Quality of Life, Leiden, 
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The Netherlands). These parameters were obtained in 1983 directly after birth. Ges-
tational age (best obstetric estimate) was based on last menstrual period, pregnancy 
testing, and ultrasound (if necessary). This was available in 1335 cases. The reliability 
of this estimate was stated to be excellent in 78% of cases; in only 7% there was a dis-
crepancy with the pediatric assessment of 2 weeks or more (pediatric maturity score = 
Dubowitz score), which is well within the variability of the scoring systems.86. 
Birth weight adjusted for gestational age and adult weight were converted to stan-
dard deviation scores (BW-sds), using Swedish and Dutch reference standards.93;94 
Subjects with a BW-sds < 0 were defined as small for gestational age (SGA) and 
subjects born with a BW-sds ≥ 0 were defined as appropriate for gestational age 
(AGA). BW-sds was considered as a measure of intrauterine growth retardation.
Informed Consent and Ethics Committee
Informed consent was obtained after oral and written information had been given. 
The ethics committees of all participating centers approved the study protocol.
Statistics
Standard methods were used for calculation of the mean, the standard deviation 
(SD), standard error of the mean (SEM), and the 95% confidence intervals (95%CI). 
To study the effect of BW-sds on renal function, independent of adult weight (sds) 
we used a multivariate regression model. In fact, we were interested in the effect of 
‘growing more than would be expected from a given birth weight’. Therefore, we first 
calculated the expected adult weight (sds), based on BW-sds, and then subtracted 
the actual adult weight (sds). This ‘residual’ was entered in the regression model 
76 leading to an effect of adult weight (sds) independent of BW-sds. The algebraic 
concept of this regression model is recently explained97. The coefficient of BW-sds 
shows the effect of BW-sds on the outcome, and the coefficient of the ‘residual adult 
weight’ shows the effect of gaining more weight than expected’ on the outcome. In 
all regression models we adjusted for gender. Statistical significance was defined 
when the p-value was < 0.05.
RESULTS
Of 676 eligible subjects 422 participated (46.7% males) in this study (response rate 
62.4%). Subject characteristics are shown in table 1. The mean (SD) age was 19.3 
(0.2) years. The mean (SD) birth weight was 1317 (338) gram, gestational age 29.7 
(1.5) weeks and the BW-sds –0.11 (1.02). Sodium, potassium and urea concentra-
tions were in normal range in all subjects and equal in the SGA and AGA group. 
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Regression coefficients (adjusted for gender) of birth weight (both SDS and grams) 
and gestational age on renal function parameters are summarized in table 2 and 3. 
The effect of adult weight (SDS) independent on BW-sds is also mentioned in table 2. 
Creatinine concentration and glomerular filtration rate
The mean (SD) serum creatinine concentration (n=396) was 81 (10) μmol/l. All val-
ues were within normal range (51-115 μmol/l). Serum creatinine concentration was 
inversely related to BW-sds (β = -1.0; 95%CI -1.9; -0.2); so, serum creatinine concen-
tration was the highest in subjects with lowest birth weight (for gestational age). 
This relation was equal in males and females. However, creatinine concentration 
was 10.64 μmol/l higher in males compared to females (95%CI for mean difference: 
8.9;12.4, p-value < 0.001). Figure 1 shows the relation between birth weight (SDS) 
and serum creatinine concentration in males (Figure 1A) and females (Figure 1B). 
Cockcroft-Gault GFR was available for 388 subjects. The mean (SD) GFR was 107.0 
(15.8) ml/min/1.73m2 ranging between 76.7 and 210.7 ml/min/1.73m2. The mean 
GFR was 6.4 ml/min/1.73m2 higher in males than in females (95%CI 3.3-9.5). When 
the MDRD equation was used, the mean GFR (SD) was 98.0 (14.7) ml/min/1.73m2, 
Table 1: Patient characteristics.
All subjects: 
N = 422
SGA (BW-sds < 0) 
N = 215
AGA (BW-sds ≥ 0)
N = 207
P value
(t-test)
Age (yrs) 19.3 (0.2) 19.3 (0.2) 19.3 (0.2) 0.323
Males (number (%)) 197 (46.7%) 91 (42.3%) 106 (51.2%) 0.068 (χ2)
BW (gram) 1317 (338) 1144 (259) 1496 (317) < 0.001
GA (weeks) 29.7 (1.5) 30.0 (1.4) 29.4 (1.6) < 0.001
BW-sds -0.11 (1.0) -0.87 (0.78) 0.68 (0.49) < 0.001
BMI* 21.74 (3.4) 22.01 (3.4) 21.94 (3.3) 0.113
Serum creatinine (μmol/l) * 81.8 (10.2) 81.9 (9.8) 81.7 (10.6) 0.862
CG GFR (ml/min/1.73m2) * 107.0 (15.8) 105.1 (16.0) 108.9 (15.4) 0.018
MDRD GFR (ml/min/1.73m2) * 98.0 (14.7) 96.6 (13.6) 99.4 (15.8) 0.064
Serum urea (mmol/l) * 4.6 (1.1) 4.6 (1.1) 4.6 (1.2) 0.739
Serum sodium (mmol/l) * 143 (3) 143 (3) 143 (3) 0.681
Serum potassium (mmol/l) * 4.5 (0.4) 4.5 (0.4) 4.5 (0.5) 0.919
log ACR (log(mg/mmol)) *
Geometric ACR (mg/mmol)
-0.69 (0.40)
0.20 (2.52)
-0.74(0.36)
0.18 (2.27)
-0.64 (0.44)
0.23 (2.77)
0.015
Data expressed by mean ± standard deviation, except when notified differently. 
SGA: Small for gestational age; AGA: Appropriate for gestational age; BW: birth weight; GA: gestational age; BW-sds: birth 
weight adjusted for gestational age expressed by standard deviation scores; CG GFR: Cockroft-Gault glomerular filtration rate; 
MDRD GFR: simplified MDRD glomerular filtration rate; ACR: albumin creatinine ratio (log ACR values and the geometric values 
of these log transformations are shown).
P-values based on Student’s t-test, comparing AGA and SGA subjects. In the distribution of males and females χ2-test was used.
* Number of subjects ranges between 368 and 414. 
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Figure 1A and 1B: Scatterplot between birth weight (sds) (BW-sds) and serum creatinine concentration in males (1A) and 
females (1B) at the age of 19 years.
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Figure 2: Scatterplot between birth weight (sds) (BW-sds) and Cockroft-Gault glomerular filtration rate (CG GFR) at the age 
of 19 years. 
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ranging between 64.2 and 162.5 ml/min/1.73m2. Also the MDRD GFR was 14.3 ml/
min/1.73m2 higher in males than females. 
Both Cockroft-Gault GFR and MDRD GFR were positively related to BW-sds (Figure 
2), meaning that subjects with low birth weight (for gestational age) have lower GFR 
values than subjects with high birth weight (for gestational age). The coefficient for 
the CG equation was 3.0 ml/min/1.73m2 (95%CI 1.7; 4.2) and for the MDRD equa-
tion 1.2 ml/min/1.73m2; 95%CI 0.0; 2.5). Also adult weight (sds) was, independent of 
birth weight, highly associated to CG GFR (β = 6.2; 95%CI 5.2;7.2) but not to MDRD 
GFR (β = -0.1; 95%CI –1.1;0.8). 
Birth weight was also related to serum creatinine concentration and GFR. An in-
crease of 100 grams in birth weight corresponded with a decrease of serum creati-
nine concentration of 0.39 μmol/l (95%CI: -0.642;-0.127) and an increase in GFR of 
1.129 ml/min/1.73m2 (95%CI: 0.672;1.586).
Creatinine concentration and GFR were not related to gestational age (β = -0.2; 
95%CI –0.7; 0.4 for creatinine concentration and β = 0.9; 95%CI –0.2; 1.9 for GFR). 
Data are shown in table 3. 
Microalbuminuria
One or two morning urines were available in 404 subjects. Thirty-one females were 
excluded from data analyses because the urine was obtained within their men-
struation period. In 5 subjects data on laboratory results were missing, leaving 368 
subjects for data analyses. In 77 subjects only 1 morning urine was available for 
analyses. The mean ACR did not differ from the average ACR in subjects with 2 avail-
able morning urines (mean difference 0.14 mg/mmol, 95%CI: -0.29;0.56). 
The prevalence of microalbuminuria (ACR > 2.2 mg/mmol) in the total group was 
2.7% (Table 4). The prevalence in SGA subjects (3.8%) was 2.4 times higher (95%CI 
0.6-9.3) than in the AGA subjects (1.6%). The mean (SD) ACR in SGA subjects was 
0.51 (1.43) mg/mmol and in the AGA subjects 0.29 (0.54) mg/mmol (mean differ-
ence 0.21 mg/mmol (95%CI: –0.01;0.44)). This trend was confirmed in a regression 
model, showing that subjects with lower birth weights (sds) had higher ACR values 
compared to subjects with higher birth weights (sds) (β = -0.11 95%CI –0.22; 0.01). 
As the distribution of ACR was left-sided skewed (mean (SD): 0.40 (1.09), range: 
0.04;15.14, and skewness 9.3), we examined whether the relation remained present 
after logarithmic transformation (log-ACR mean (SD): -0.7 (0.4), range: -1.44; 1.18, 
and skewness 1.3). Birth weight (sds) was still significantly related to ACR (ACR = 
10 -0.05 * BW sds, 95%CI for β: -0.09; -0.01) as shown in figure 3 (p=value 0.02). ACR also 
decreased with increase of actual birth weight (per 100 gram) (ACR = 10 -0.02 * BW per 100 
gram , 95%CI for β: -0.03; -0.01). Gestational age was not related to microalbuminuria 
in our study (Table 3).
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DISCUSSION
We have found an association between the extent of intrauterine growth retarda-
tion and renal functions of young adults born very prematurely (GA < 32 weeks). 
On average, our subjects born with low birth weights (sds) had lower GFR, higher 
serum creatinine concentration and higher microalbumin excretion at the age of 19 
years. These associations were independent on adult weight (sds). 
Table 4: Distribution of microalbuminuria in morning urines
All subjects SGA (BW-sds < 0) AGA (BW-sds ≥ 0)
Number % Number % Number %
No microalbuminuria
(ACR < 2.2)
358 97.3% 178 96.2% 180 98.4%
Microalbuminuria
(ACR > 2.2 and ACR < 22.6)
10 2.7% 7 3.8% 3 1.6%
Total 368 100% 185 100% 183 100%
SGA: Small for gestational age; AGA: Appropriate for gestational age; BW-sds: birth weight adjusted for gestational age 
expressed by standard deviation scores; ACR: albumin creatinine ratio BWsds
3210-1-2-3-4
CG
 G
FR
 (m
l/m
in/
1.7
3 m
2)
220
200
180
160
140
120
100
80
60
BWsds
3210-1-2-3-4
log
 A
CR
 (m
g/m
mo
l)
1,5
1,0
,5
0,0
-,5
-1,0
-1,5
Figure 3: Scatterplot between birth weight (sds) (BW-sds) and the logarithm of Albumin creatinine ratio (ACR) at the age of 19 
years. 
66
C
ha
pt
er
 3
.3
Controversy exists which equations for GFR estimates real GFR best. The Cockroft-
Gault (CG) equation is suggested to be more accurate in healthy subjects with nor-
mal GFR values, but is dependent on adult weight.119 The (simplified) MDRD formula 
is not dependent on adult weight, but is based on patients with renal dysfunction 
and therefore suggested as less reliable in healthy individuals. To estimate GFR the 
CG equation is the most common used in clinical settings in adults. Adult weight 
was a very strong predictor for CG GFR, acting as a factor in the causal pathway 
when multivariate regression analysis is used. Using the multivariate regression 
analysis with residuals, as explained in the statistical section, the influence of this 
causal pathway factor was prevented. The relation between birth weight (sds) and 
GFR we found was therefore not influenced by adult weight (sds). Moreover, both 
CG and MDRD GFR estimations show a positive significant relation between BW-sds 
and GFR, with a 1.2 to 3.0 ml/min/1.73m2 increase in GFR per 1 BW-sds increase.
In this study also actual birth weight (grams) was related to renal outcome at 19 
years. However, no convincing relation between gestational age (up to 32 weeks of 
age) and renal function was found. Therefore, it is most likely that not actual birth 
weight (grams) is the important predicting factor for renal outcome, but indeed 
the extent of intrauterine growth retardation (birth weight SDS). If not, the relation 
between GA and renal function would have been much stronger. 
A potential selection bias may have been introduced as a result of a response of 
62.4%. Non-responders were hard to trace or not willing to participate, mainly due 
to a lack of time, lack of interest or fear of medical examination. Unfortunately, spe-
cific information on renal function, renal diseases and renal deaths in non-respond-
ers were not available. However, BW, GA and BW-sds were not significantly different 
between responders and non-responders. So, therefore the effect of a potential 
selection bias on our results is probably limited.
Our findings suggest the possibility that the normal process of aging, with a de-
cline of GFR after the age of 20 years 120, may be enhanced after IUGR and preterm 
birth. We cannot predict if and how much the relation between birth weight (SDS) 
and renal function will strengthen with age. To study the effect on the incidence 
of renal function decline and renal disease in later life follow-up of our cohort is 
recommended. 
Our results are in agreement with several animal studies, showing that renal 
function is decreased after IUGR.46;121 Also, several human studies have linked IUGR 
with renal function.17;18;45 In the Saskatchewan population in Canada women with 
ESRD were 3 times more likely to have had low birth weight compared to subjects 
without ESRD.17 In this study increased in maternal age, known as a risk factor for 
prematurity and low birth weight was also related to ESRD of the offspring at adult 
age. Lackland described a U-shaped quadratic association between birth weight 
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and early-onset of chronic renal failure in subjects living in the southeast of the 
United States (US).18 In this study, neither differences in gender nor race was seen. 
However, as low birth weight is suggested to be more common in black people and 
in the Southeastern part of the US, this may explain the increased prevalence of 
ESRD in that region. Another recent study in 668 aboriginal subjects between 4 and 
72 years showed that subjects with the lowest birth weights had smallest kidneys 
(measured by ultrasound), and the subjects with the smallest kidney size had the 
highest blood pressure and the highest rates of albuminuria (ACR ≥ 34 mg/mmol).34 
Also, nephron number was inversely related to glomerular volume, suggesting that 
glomerulomegaly is a marker of an increased risk of groups of patients or popula-
tions with progressive renal disease.44 These studies all show that in these popula-
tions at risk for ESRD birth weight is lower, supporting the ‘hyperfiltration theory’ 
as a possible mechanism saying that IUGR is a risk factor for the development of 
progressive renal disease.41
In our study the overall prevalence of microalbuminuria was 2.7%. This prevalence 
was two times higher in SGA subjects than in AGA subjects. In a linear regression 
analysis we confirmed a relation between birth weight and microalbuminuria. SGA 
subjects have an increased risk for higher microalbumin concentrations, and there-
fore may be at risk to develop real microalbuminuria later in life. 
The relations between birth weight (sds) and renal function in our study are weak, 
and do not have clinical implications for the subjects at this age. The knowledge of 
decrease in glomerular filtration rate after the age of 20 years and the increase in 
the prevalence of microalbuminuria, and therefore the risk for developing progres-
sive renal disease, shows the importance of these small differences at this young 
age.120;122 Follow-up of our cohort is recommended to trace subjects with early de-
crease in renal function and to study whether the relation between birth weight 
(sds) and renal function will straighten with increase of age. 
In conclusion, our data support the hypothesis that in subjects born prematurely 
IUGR affects renal development in an unfavourable way, possibly leading to pro-
gressive renal failure in later life. 
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POPS Nephrology study: Study design, blood pressure, renal 
function, and renal ultrasound
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STUDY POPULATION
Three groups of young adults were recruited to participate in our study. The indi-
viduals in the first group (n=23) were born very premature (< 32 weeks) and small 
for GA (SGA). The second group (n=29) consisted of individuals who were born very 
premature, but appropriate for GA (AGA). Individuals in the third group (n=30) were 
all born full term and appropriate for GA (Controls). 
The SGA and AGA group were recruited from the database of the Project of Pre-
terms and Small for GA infants (POPS cohort) as described in chapter 3.1 of this the-
sis. The cohort contains 94% of all individuals born alive in 1983 in the Netherlands 
with a GA < 32 weeks and/or a birth weight < 1500 grams (n=1338). In 2002-2003 
62.4% of the individuals who were alive (n=934) at the age of 19 years participated 
in the POPS 19 study (n=596). In our new study only individuals who participated in 
the POPS 19 study and who were born with a GA <32 weeks were eligible for inclu-
sion in the POPS Nephrology study (n=422).
Perinatal parameters (such as BW, GA, Apgar score) and obstetric parameters (such 
as maternal hypertension, use of medication during pregnancy, smoking during 
pregnancy) of these prematurely born individuals were derived from the original 
POPS database (TNO Quality of Life, Leiden, The Netherlands). These parameters 
were obtained in 1983 directly after birth in all preterm born participants. These 
data were not available in controls.
GA (best obstetric estimate) was based on last menstrual period, pregnancy test-
ing, and ultrasound (if necessary). The reliability of this estimate was stated to be 
excellent in 78% of cases; in only 7% there was a discrepancy with the pediatric 
assessment of 2 weeks or more (pediatric maturity score = Dubowitz score), which 
is well within the variability of the scoring systems.86 Birth weight was converted to 
standard deviation scores adjusted for GA (BW-sds) using Swedish reference stan-
dards93 and considered as a measure of IUGR. To convert adult weight in standard 
deviation scores Dutch reference standards were used.94
Preterm born SGA individuals had a BW-sds < -2 SDS and preterm born AGA indi-
viduals had a BW-sds < 2 but > 0 SDS. As the eligible AGA group of individuals was 
large (n=205), the individuals living close to the hospital were recruited first. 
The control group consisted of students born between January 1st 1982 and 
December 31st 1984. They were recruited in the hospital region by advertisement. 
Data on birth weight and GA in the control group were collected by birth records, 
or when unavailable by mother’s recall. Individuals with a GA < 37 weeks or a birth 
weight < 2500 gram were excluded from the study. 
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Exclusion criteria for all participants were 1) the use of antihypertensive medication, 
2) contraindication for the use of plastic cannula, or study medication (Inulin, PAH or 
dopamin), females within their menstrual period of pregnancy, and vegetarians.
DATA OBTAINMENT
Participants were asked to visit the ErasmusMC-Sophia Children’s Hospital during 
1 day. Prior to this visit the participant was asked to collect 3 morning urines. Am-
bulant blood pressure monitoring (ABPM) was obtained after visiting the hospital 
during 24 hours. A time line for study protocol is given in Figure 1. 
Day 1 Morning urine collection
Day 2 Morning urine collection
Day 3
Morning urine collection
Programme day 3
3.45 p.m. Start 24 hour ambulant blood pressure monitoring
Day 4
3.45 p.m. Finish 24 hour ambulant blood pressure monitoring
Figure 1A: Urine collection en blood pressure monitoring
8.00-9.00
Informed consent
3 baseline blood pressure measurements
Saline infusion 10 ml/kg/h + blood withdrawal (Creatinine, urea, Na, K)
9.00-10.00
Renal ultrasound
Inulin and PAH bolus injection (45 mg/kg Inulin and 8 mg/kg PAH) 
Start continuous infusion Inulin and PAH (42 mg/min Inulin and 20 mg/min 
PAH)
10.00-11.00
Start baseline renal function test (t=0): voiding or blood withdraw every 15 
minutes and 2 blood pressure measurements
11.00-12.00  Renal function test
12.00-13.00 Lunch
13.00-14.00
Start dopamine infusion (2μg/kg/min)
Start stimulated renal function test (t=150): voiding or blood withdraw every 
15 minutes and 2 blood pressure measurements
14.00-15.00 Renal function test
15.00-16.00
Renal function test
Start 24 hour ambulant blood pressure monitoring
Figure 1B: Programme day 3
Figure 1: Time line POPS Nephrology study
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Baseline blood pressure 
Three baseline BP measurements (minimal interval 1 minute) in rest, at the non-
dominant arm, in sitting position were obtained using a calibrated automatic blood 
pressure device (Hewlett Packard). The mean of the three baseline BP measurements 
were calculated and compared with the results of the ABPM (see below).
Blood samples
Blood samples were withdrawn to measure creatinine, urea, Na and K directly and to 
measure renin concentration. Timed blood samples to measure Inulin, PAH and Na 
concentrations were withdrawn during the renal function test. 
Renal ultrasound
Renal ultrasound was performed by one of the three pediatric radiologists accord-
ing a standardized protocol. Subjects were measured in prone position with a Phil-
ips Zs2U or ZSJ5 scanner with a C5-2 curved array transducer (Philips BV Nederland, 
The Netherlands).
Measures of maximal bipolar kidney length, width and thickness were obtained 
for both right and left kidney. Renal width and thickness were measured at the 
level of the kidney hilum. Renal volume (ml) was calculated using the formula 
(π / 6) * length (cm) * width (cm) * thickness (cm). Cortical thickness was defined 
as the distance between the external surface of the kidney and top of the medulla. 
As absolute renal size is known to be associated with body size, we calculated the 
relative kidney length and volume (RKL and RKV respectively).123 RKL was calculated 
dividing renal length by body height. Relative kidney volume was calculated divi-
ding renal volume by body surface area (√ (body height (m) * weight (kg)) / 3600). 
Renal and ureterovesical anomalies were described.
Renal function
Microalbuminuria Three morning urines were obtained at three consecutive days 
prior to the renal function test to measure albumin creatinine ratio (ACR: mg/mmol). 
If the mean of three ACR values was higher as 2.2 mg/mmol, the subject was consi-
dered as microalbuminuric.87
Baseline renal function Subjects were instructed to have a light, fructose free 
breakfast. Baseline GFR and ERPF were estimated by the mean of three 30 minutes 
clearance periods with respectively Inulin (Inutest 25%, Fresenius, Austria) and ρ-
aminohippuric acid (PAH: sodium aminohippurate 20%, MSD). A single bolus injec-
tion of 45 mg/kg Inulin and 8 mg/kg PAH preceded the continuous infusion of 42 
mg/min Inulin and 20 mg/min PAH. Subjects were instructed to void 45 minutes 
(t=0) after the bolus injection and at t=30, t=60 and t=90 minutes. Blood samples 
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were taken, from the opposite arm where medication was infused, in the middle of 
each clearance period at t=15, t=45 and t=75 minutes. 
Stimulated renal function After baseline renal function test, the subjects were 
given a protein rich lunch.124;125 Forty minutes after lunch, a low dose dopamin 
infusion was started at a rate of 2μg/kg/min.124 After five minutes three new clear-
ance periods were started: Voiding at t=150, t=180, t=210, and t=240 and blood 
samples at t=165, t=195, and t=235.
Calculation of GFR, ERPF and Fractional sodium excretion GFR and ERPF ad-
justed for body surface area were calculated using the equation: UInul/PAH * Volume 
(ml) * 1.73 / PInul/PAH * duration (min) * BSA, in which UInul/PAH and PInul/PAH reflects the 
concentration (mg%) of Inulin or PAH in the urine and plasma respectively, and BSA 
the body surface area (√ height (m) * weight (kg) / 3600). The filtration fraction (FF) 
was calculated by dividing GFR by ERPF (*100%). 
To monitor systemic effects of dopamin infusion, we obtained systolic and diastolic 
blood pressure (SBP, DBP) during the test. Also fractional urinary excretion of sodi-
um (FeNa) was evaluated before and after renal stimulation, by dividing the sodium 
clearance by the Inulin clearance.
ABPM 
After the renal function tests were finished, systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were measured with a Spacelabs™ 90207 ambulant blood pres-
sure monitor (ABPM) at the nondominant upperarm during 24 hours. Cuff size was 
adjusted for upperarm length as described previously.103 Participants were instructed 
to keep their arm steady during measurement. Reading frequency was programmed 
for every 20 minutes from 7 AM to 11 PM (daytime) and for every hour between 11 
PM and 7 AM (night time). Mean daytime, nighttime and overall BP values and abso-
lute and relative differences in day and nighttime BP were calculated within the three 
groups. Mean arterial pressure was calculated using (SBP + 2* DBP)/3. Individuals 
were categorised BP stages according the JNC VII criteria.95
Laboratory assays
Analyzes were determined on a Hitachi 917 (Roche Diagnostics). Electrolytes were 
measured by using Ion Selective Electrodes. Enzymatic assays were used for the de-
termination of creatinine (CREA Plus®) and urea in urine and serum. For the determi-
nation of microalbumin in urine an immunoturbidimetric assay was used. Inulin and 
PAH concentration was measured in all renal test blood and urine samples using the 
automatic Anthrone and Bratton-Marshall technique.126;127 Renin (ng Al/mg per hour) 
was quantitated by its capacity to generate angiotensin I from excess substrate angio-
tensinogen, measured by an in-house radioimmunoassay, as described previously.128 
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INFORMED CONSENT AND ETHICS COMMITTEE
Informed consent was obtained after oral and written information had been given. 
The ethics committee of the Erasmus MC – Sophia Children’s Hospital, University 
Medical Center Rotterdam approved the study protocol.

Chapter 4.2
Very preterm birth is risk factor for increased systolic blood 
pressure and prehypertension at young adult age
-
MG Keijzer-Veen, A Dülger, FW Dekker, J Nauta, AJ van der Heijden
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ABSTRACT 
Objective: This study was conducted to investigate the effect of prematurity and 
IUGR on young adult blood pressure.
Design: Prospective follow-up of very preterm born individuals at the age of 20 years 
compared with controls.
Setting: Assessing risk factors for primary care.
Participants: We included 29 appropriate and 21 small for GA (AGA, SGA) very pre-
mature individuals (GA < 32 weeks), and 30 appropriate birth weight and full term 
born controls (37-42 weeks) at 20 years of age.
Interventions: Ambulant blood pressure was monitored during 24 hours at the non-
dominant arm with a Spacelabs™ 90207 device.
Main outcome measures: Daytime blood pressure values (7 AM to 11 PM) measured 
with a 20-minute interval and night time blood pressure values (11 PM to 7 AM) 
measured with a 60-minutes interval.
Results: The mean (SD) daytime SBP in SGA and AGA individuals was 122.7 (8.7) and 
123.1 (8.5) mmHg respectively, and 3.6 mmHg (95%CI:-0.9;8.0) versus 4.2 mmHg 
(95%CI:0.4;8.0) higher than in controls (119.6 (7.6)). Daytime DBP and night time SBP 
and DBP were equal. Elevated blood pressure (>140/90) was 1.6 times (95%CI:1.0;2.4) 
more common in AGA preterms compared with controls. 
Conclusions: We conclude that very preterm born individuals have higher daytime 
adult systolic blood pressure and higher risk of hypertension at young adult age. 
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INTRODUCTION
In the last decades it has frequently been reported that intrauterine growth retar-
dation (IUGR) affects the normal development of organs, such as the kidney, the 
pancreas and the vascular system, leading to an increased risk for hypertension and 
/ or cardiovascular diseases.3;12;90;92
Impaired fetal kidney development is considered as one important pathway in 
the development of hypertension after IUGR birth.116;129;130 IUGR is associated with a 
decreased number of nephrons, leading to a decreased filtration surface area, which 
may lead to hyperfiltration, glomerular hypertension, glomerular damage, and 
changes in the renin angiotensin system (RAS) with an increase in systemic BP.41;58;59 
In addition to IUGR, premature birth may also contribute to the development of 
adult diseases.5;65-67;131 In very premature born neonates many organ systems, such 
as lungs, pancreas, and kidneys are not fully developed yet. After premature birth 
the postnatal organ development may not be equal compared with the prenatal 
organ development in individuals born at term, but data are limited.63 Recently, we 
have demonstrated unfavorable renal function, but equal blood pressure at the age 
of 19 years in very preterm born individuals born with IUGR compared with very 
preterm born individuals with appropriate birth weight.132;133 It was suggested that 
the prevalence of hypertension was increased, but controls were lacking.
In this article we describe the results of a prospective follow-up study at the age of 
20 years, in individuals who were born very premature and in controls born after full 
gestation. We obtained renin concentrations and BP. BP was measured both by an 
initial screening and by a 24-hour ambulant blood pressure monitor. The first objec-
tive of the study was to determine whether IUGR was associated with increased BP 
within young adults born very preterm. The second objective was to determine the 
effect of gestational age (GA) on BP at young adult life. Third, we evaluated the renin 
concentration in these individuals in relation to BP.
METHODS
Study population
Three groups of young adults were recruited to participate in our study. The indi-
viduals in the first group were born very premature (< 32 weeks) and small for GA 
(SGA). The second group consisted of individuals who were born very premature, 
but appropriate for GA (AGA). Individuals in the third group were all born full term 
and appropriate for GA (Controls). 
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The SGA and AGA group were recruited from the database of the Project of Pre-
terms and Small for GA infants (POPS cohort) 86. This cohort contained 94% of all in-
dividuals born alive in 1983 in the Netherlands with a GA < 32 weeks and/or a birth 
weight < 1500 grams (n=1338). In 2002-2003 62.4% of the individuals who were 
alive (n=934) at the age of 19 years participated in the POPS 19 study (n=596).133 In 
our new study only individuals who participated in the POPS 19 study and who were 
born with a GA <32 weeks were eligible for inclusion (n=422).
Perinatal parameters (such as BW, GA, Apgar score) and obstetric parameters 
(such as maternal hypertension, use of medication during pregnancy, smoking dur-
ing pregnancy) were derived from the original POPS database (TNO Quality of Life, 
Leiden, The Netherlands). These parameters were obtained in 1983 directly after 
birth in all preterm born participants. These data were not available in controls.
GA (best obstetric estimate) was based on last menstrual period, pregnancy test-
ing, and ultrasound (if necessary). The reliability of this estimate was stated to be 
excellent in 78% of cases; in only 7% there was a discrepancy with the pediatric 
assessment of 2 weeks or more (pediatric maturity score = Dubowitz score), which 
is well within the variability of the scoring systems 86. Birth weight was converted to 
standard deviation scores adjusted for GA (BW-sds) using Swedish reference stan-
dards 93 and considered as a measure of IUGR. To convert adult weight in standard 
deviation scores Dutch reference standards were used 94. 
For the SGA group all individuals of the POPS 19 study group with the lowest 
BW-sds (<-2) were asked to participate in our study (n=26). For the AGA group in-
dividuals with a BW-sds between 0 and 2 were asked to participate, starting with 
the highest BW-sds. As the number of eligible individuals in the AGA group was 
very large (n=205), the individuals living closer to the hospital were recruited first. 
The control group, containing students born between January 1st 1982 and Decem-
ber 31st 1984, was recruited in the hospital region by advertisement. Data on birth 
weight and gestational age in the control group was collected by birth records or, 
when unavailable, by mother’s recall.
Data collection
Three baseline BP measurements (minimal interval 1 minute) after at least 15 
minutes of rest, at the nondominant arm, in sitting position were obtained using 
a calibrated automatic blood pressure device (Hewlett Packard). Thereafter, sys-
tolic blood pressure (SBP) and diastolic blood pressure (DBP) was measured with a 
Spacelabs™ 90207 ambulant blood pressure monitor (ABPM) at the nondominant 
upperarm during 24 hours. Cuff size was adjusted for upperarm length as described 
previously.103 Participants were instructed to keep their arm steady during mea-
surement. Reading frequency was programmed for every 20 minutes from 7 AM to 
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11 PM (daytime) and for every hour between 11 PM and 7 AM (night time). Mean 
daytime, night time and overall BP values and absolute and relative differences in 
day and night time BP were calculated within the three groups. Mean arterial pres-
sure was calculated using (SBP + 2* DBP)/3. Individuals were categorised BP stages 
according the JNC VII criteria.95
A blood sample was withdrawn in rest, after baseline BP measurement. Renin 
(ng Al/mg per hour) was quantitated by its capacity to generate angiotensin I from 
excess substrate angiotensinogen, measured by an in-house radioimmunoassay, as 
described previously.128
The mean of the three baseline BP measurements were calculated and compared 
with the results of the ABPM.
Informed Consent and Ethics Committee
Informed consent was obtained after oral and written information had been given. 
The ethics committee of the Erasmus MC – Sophia Children’s Hospital, University 
Medical Center Rotterdam approved the study protocol.
Statistics
Data were imported and analysed by a SPSS 11.0 (Inc, Chicago) software programme. 
Results are presented as mean, standard deviation (SD) and 95% confidence intervals 
(95%CI). Multivariate linear regression analyses adjusted for gender were performed 
to analyze the differences in BP and renin concentration between the three groups. 
Differences between SGA and AGA participants were accounted as differences due 
to IUGR, and differences between AGA and controls were accounted as differences 
due to GA. We also compared the BP values obtained by initial screening and 24-
hour BP monitoring, with Bland and Altman plots and 95% limits of agreement.
The relation between IUGR and BP was analyzed with the regression model with 
‘unstandardized residuals’, as we described recently.97 This because birth weight 
(SDS) or IUGR is related to adult weight (SDS), and adult weight is related to BP 
(causal pathway). In this model the relation between BW-sds and adult weight (SDS) 
is calculated. The residual for adult weight, expressing the increase in adult weight 
upon a given birth weight (SDS), is entered in the regression model. 
The prevalence of hypertension within the groups and the relative risks (RR) with 
95%CI were calculated between groups. Differences were considered statistical sig-
nificant at the level of 0.05. 
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RESULTS
Eighty-two individuals participated in the study (23 SGA, 29 AGA and 30 controls). 
Of 23 SGA individuals, 2 individuals were excluded from data analysis: 1 because of 
very frequent premature heartbeats leading to unreliable BP measurement, and an-
other as a result of an unrelated allergic episode prior to the ABPM measurement. 
Baseline characteristics of the remaining 80 individuals in the 3 groups are shown in 
Table 1. Weight and height were statistically-significantly lower in SGA individuals 
compared with AGA and controls. BMI at age 20 did not differ between the three 
groups (SGA 21.6 kg/m2, AGA 22.1 kg/m2 and controls 22.9 kg/m2). Maternal hyper-
tension during pregnancy and alterations on cardiotocographic measurement were 
more common in SGA compared with AGA subjects, but other prenatal, perinatal 
and postnatal parameters were not. (Table 2) No association between these para-
meters and adult blood pressure was present in these preterm born individuals. 
Birth weight (g), BW-sds and GA were not different between men and women. 
Men had greater body height (mean difference 13.4 cm 95%CI 10.0;16.9) and higher 
body weight (mean difference 12.3 kg 95%CI 7.7;17.0), but equal BMI (mean diffe-
rence 0.6 kg/m2 95%CI –0.7;1.9) compared with women. 
Ambulant Blood Pressure Monitor
Daytime SBP was 6.6 mmHg (95%CI 3.2;10.1) higher in men (125.6 mmHg) than in 
women (119.0 mmHg). Similar differences were found for overall, night time and 
baseline SBP. DBP and MAP were not statistically-significantly different between 
men and women. The daytime heart frequency was 5.8 bpm (95%CI 2.2;9.3) lower 
in men than in women, with similar differences for overall, night time and baseline 
HF. In women the mean nocturnal dip of MAP was 15.0%, and in men 12.1% (mean 
difference 2.9% with 95%CI 0.5;5.3 and p value 0.02). Further analyses comparing BP 
values between the three groups were adjusted for gender.
Prematurity Overall, daytime and baseline SBP was higher in AGA individuals com-
pared with controls (Table 3). At baseline SBP was 8.4 mmHg higher (95%CI 4.1;12.7, 
p-value < 0.001), but baseline DBP did not differ. Also, ambulant daytime SBP was 
4.2 mmHg higher in AGA individuals compared with controls (95%CI 0.4; 8.0, p-value: 
0.03). Night time SBP did not differ statistically-significantly between AGA and con-
trols (AGA 3.6 mmHg higher with 95%CI -0.9; 8.1, p-value: 0.12). The nocturnal SBP dip 
did not differ between AGA and controls. Baseline MAP was higher in AGA individuals 
compared with controls. Ambulatory DBP, HF, and MAP did not differ between the 
controls and AGA. 
IUGR No significant differences in SBP, DBP, MAP and HF were present between the 
SGA and AGA group, both during day and night. This implies that IUGR in individuals 
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born very preterm does not influence young adult BP. Crude mean values and mean 
differences adjusted for gender are presented in Table 3.
Both IUGR and prematurity Baseline SBP was 7.1 mmHg higher in SGA individuals 
than in controls (95%CI 2.0;12.0, p-value:0.007). Daytime SBP was 3.6 mmHg higher in 
SGA individuals than in controls, but the difference did not reach significance (95%CI 
-0.9;8.0, p-value: 0.111). Night time SBP, and both day and night DBP, MAP and HF did 
not differ between SGA individuals and controls. 
Birth weight adjusted for GA (BW-sds) was not related to adult daytime SBP, adjus-
ted for gender and residual adult weight.97 Residual adult weight remained related 
to daytime SBP. BMI was not related to adult daytime SBP. BW-sds was positively 
related to adult weight (sds) with a regression coefficient of 0.389 SD/SD (95%CI 
0.223;3.079, p-value < 0.001). Adult weight (sds) was positively related to adult day-
time SBP (β = 1.5 mmHg/SD, 95%CI 0.1;2.8 p-value 0.03) adjusted for gender. 
Both actual birth weight (grams) and GA (GA: weeks) were negatively related to 
adult SBP. The regression coefficient was –0.14 mmHg per 100 gram increase in BW 
(95%CI –0.3;0.0) and –0.39 mmHg / week increase of gestation (95%CI –0.72;-0.06). 
When only preterm individuals (SGA and AGA) were included in this analysis, the 
point estimate became -0.09 mmHg per 100 grams BW and -0.56 mmHg per week 
GA, but significance disappeared in both comparisons. 
Table 2: Presence of obstetric and perinatal parameters in the premature born individuals (SGA and AGA).
Obstetric and Perinatal parameters SGA (21)
Number                    %
AGA (29)
Number                    %
Hypertension during pregnancy 13 62 % 2 7 %
Diabetes Gravidarum 1 5 % 2 7 %
Blood group Antagonism 0 0% 0 0 %
Pre-existing maternal disease 2 10 % 1 3 %
Premature rupture of membranes 2 10 % 8 28 %
Amnionitis 0 0 % 3 10 %
Cardiotocographic deterioration 15 (3 unknown) 71 % 4 (7 unknown) 14 %
Use of corticosteroids 2 10 % 8 28 %
Unfortunate Apgar score 5 
minutes
1 (2 unknown) 5 % 1 (2 unknown) 3 %
Infant respiratory distress 
syndrome
5 24 % 16 55 %
Sepsis 8 38 % 13 45 %
Convulsions 0 0% 0 0%
88
C
ha
pt
er
 4
.2
Ta
bl
e 3
: B
loo
d p
re
ssu
re
 an
d r
en
in
 co
nc
en
tra
tio
n
SG
A
N 
= 
21
SG
A 
vs
 A
GA
M
ea
n 
di
ffe
re
nc
e
(9
5%
 C
I) 
Ad
ju
st
ed
 fo
r g
en
de
r
AG
A
N 
= 
29
AG
A 
vs
 C
on
tro
ls
M
ea
n 
di
ffe
re
nc
e
(9
5%
 C
I) 
Ad
ju
st
ed
 fo
r g
en
de
r
Co
nt
ro
ls
N=
30
SG
A 
vs
 C
on
tro
ls 
M
ea
n 
di
ffe
re
nc
e
(9
5%
 C
I) 
Ad
ju
st
ed
 fo
r g
en
de
r
Ba
se
lin
e 
SB
P 
(m
m
Hg
)
12
4.
1 
(1
0.
9)
1.
3
(-4
.1
;6
.6
)
12
5.
4 
(9
.9
)
-8
.4
(-1
2.
7;
-4
.1
) ‡
11
7.
7 
(8
.2
)
-7
.1
(-1
2.
1;
2.
0)
 ‡
Ba
se
lin
e 
DB
P 
(m
m
Hg
)
70
.0
 (9
.8
)
0.
0
(-5
.1
;5
.0
)
70
.0
 (7
.8
)
-1
.9
(-5
.8
;2
.0
)
68
.0
 (7
.1
)
-1
.8
(-6
.5
;3
.0
)
Da
yt
im
e 
SB
P 
(m
m
Hg
)
12
2.
7 
(8
.7
)
0.
4
(-3
.9
;4
.8
)
12
3.
1 
(8
.5
)
-4
.2
(-8
.0
;-0
.4
) †
11
9.
6 
(7
.6
)
-3
.6
(-8
.0
;0
.9
)
Ni
gh
t t
im
e 
 S
BP
 (m
m
Hg
)
10
7.
9 
(8
.3
)
3.
0
(-1
.7
;7
.7
)
11
0.
9 
(9
.1
)
-3
.6
(-8
.1
;0
.9
)
10
7.
9 
(9
.4
)
-0
.3
(-5
.4
;4
.7
)
No
ct
ur
na
l S
BP
 d
ip
 (%
)
12
.0
 (5
.3
)
-2
.0
(-4
.8
;0
.7
)
9.
9 
(4
.4
)
-0
.1
(-2
.4
;2
.2
)
9.
8 
(9
.5
)
-2
.2
(-5
.0
;0
.6
)
Da
yt
im
e 
DB
P 
(m
m
Hg
)
73
.0
 (8
.0
)
-0
.8
(-4
.6
;2
.9
)
72
.2
 (5
.1
)
-0
.3
(-3
.3
;2
.6
)
71
.7
 (6
.0
)
-1
.0
(-4
.9
;2
.9
)
Ni
gh
t t
im
e 
DB
P 
(m
m
Hg
)
58
.1
 (7
.3
)
1.
6
(-2
.1
;5
.3
)
59
.6
 (5
.6
)
-1
.0
(-4
.3
;2
.4
)
58
.8
 (7
.1
)
0.
8
(-3
.4
;4
.9
)
No
ct
ur
na
l D
BP
 d
ip
 (%
)
20
.3
 (7
.6
)
-3
.0
(-7
.0
;1
.0
)
17
.3
 (6
.4
)
1.
1
(-2
.2
;4
.4
)
18
.1
 (6
.5
)
-2
.0
(-6
.0
;2
.0
)
Re
ni
n 
* (
ng
 A
l/m
l/h
)
1.
77
 (0
.7
8)
0.
42
(-0
.0
8;
0.
92
)
2.
18
 (0
.9
3)
0.
05
(-0
.4
8;
0.
57
)
2.
26
 (1
.0
8)
0.
48
(-0
.0
9;
1.
05
)
Da
ta
 ex
pr
es
se
d b
y c
ru
de
 m
ea
n ±
 st
an
da
rd
 de
via
tio
n.
 SG
A:
 Sm
all
 fo
r G
A;
 AG
A:
 A
pp
ro
pr
iat
e f
or
 G
A;
 SB
P:
 sy
sto
lic
 bl
oo
d p
re
ssu
re
; D
BP
: d
ias
to
lic
 bl
oo
d p
re
ssu
re
. *
 Re
ni
n c
on
ce
nt
ra
tio
n i
n 2
0 S
GA
 in
di
vid
ua
ls.
 
Ba
se
lin
e v
alu
es
 w
er
e m
ea
su
re
d a
t a
n i
ni
tia
l s
cre
en
in
g w
ith
 H
ew
let
t P
ac
ka
rd
 de
vic
e. 
Da
yt
im
e a
nd
 ni
gh
t t
im
e v
alu
es
 w
er
e m
ea
su
re
d w
ith
 an
 am
bu
lat
or
y b
loo
d p
re
ssu
re
 de
vic
e (
Sp
ac
ela
bs
™)
 du
rin
g 2
4 
ho
ur
s. 
† P
-v
alu
e <
 0.
05
, ‡
 P-
va
lu
e <
 0.
01
Blood pressure in POPS Nephrology study 89
Hypertension prevalence
Table 4 shows the prevalence rates of hypertension within the three groups. The 
distribution of normal, prehypertension and hypertension stage 1 was equal (χ2 
0.006, p-value 0.94) between SGA and AGA individuals. The distribution of AGA 
differed significantly from controls (χ2 4.051, p-value 0.04). Elevated BP (either pre-
hypertensive stage or hypertension) was 1.6 (95%CI:1.0;2.4, p-value =0.05) times 
more common in AGA individuals, and 1.5 (95%CI:1.0;2.4, p-value =0.08) times more 
common in SGA compared with controls. No difference in prevalence of elevated BP 
was present between SGA and AGA individuals. 
Renin concentration 
Renin concentration (ng Al/ml per hour) was available in 79 of the 80 individuals 
(Table 3). Renin concentration was not significantly higher in men than in women 
(mean difference: 0.33 ng Al/ml/h, 95%CI –0.1:0.7). In SGA individuals renin concen-
tration was 0.42 lower compared with AGA individuals (95%CI –0.08;0.92, p-value: 
0.10) and 0.48 lower compared with controls (95%CI -0.09;1.05, p-value: 0.10). No 
relation between renin concentration and systolic or DBP was found. In a linear re-
gression analysis renin concentration was not related to birth weight as a continu-
ous variable (both SDS and g) or to GA.
Comparison of baseline BP measurement with ABPM
The baseline SBP overestimated the daytime systolic ABPM with 0.5 mmHg (95% 
limits of agreement of –14.7 to 15.7). The baseline DBP underestimated the diastolic 
ABPM with -2.9 mmHg (95% limits of agreement: -15.4;9.5).
Table 4: Prevalence of hypertension
SGA AGA Controls
N (%) N (%) N (%)
Normal BP 6 (28.6) 8 (27.6) 16 (53.3)
Prehypertensive stage 14 (66.7) 19 (65.5) 14 (46.7)
Hypertension stage 1 1 (4.8) 2 (6.9) 0 (0)
Total 21 (100) 29 (100) 30 (100)
JNC VII criteria for hypertension95:
Normal BP: SBP < 120 mmHg and DBP < 80 mmHg
Prehypertensive stage: SBP 120-139 mmHg or DBP 80-89 mmHg
Hypertension stage 1: SBP 140-159 mmHg or DBP 90-99 mmHg
(No cases of hypertension stage 2: DBP >160 mmHg or DBP >100 mmHg)
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DISCUSSION
We found that SBP was increased at the age of 20 years in individuals born very 
prematurely (< 32 weeks) compared with full term born individuals of the same age. 
Second, IUGR did not alter this effect on SBP within these very preterm individuals. 
This suggests that prematurity is a predisposing risk factor for the development of 
increased SBP and no additional effect of IUGR within very preterm born subject is 
present. No differences in nocturnal BP or nocturnal dip were present in our study.
The results are in agreement with our previous study 133 showing a similar mean 
SBP of 123 mmHg, and a high prevalence of hypertension (10%) in individuals who 
were born very preterm recruited from the same cohort. In this previous study the 
mean of three BP measurements at one initial screening visit were used and controls 
were lacking. Therefore, 24-hour BP measurements in preterms and controls were 
used in the present study. Both studies suggest that IUGR within individuals who 
are born prematurely does not predispose to an increased BP, but that prematurity 
is the important factor. Likewise, Irving et al. has shown that BP was increased at the 
age of 24 years in individuals who were born prematurely (mean GA 33.4 weeks) 
and no effect of IUGR within this group was shown.68 A Swedish study in 165,136 
men also showed an inverse association between GA (GA), ranging from 35 - 44 
weeks, and SBP.5 
In contrast, Singhal et al. did not find an increased risk of vascular disease at the 
age of 15 years within 216 preterms (mean GA of 31 weeks) compared with at term 
born individuals of the same age.69 Also a large cohort study in Brazil could not 
detect a difference in BP values between the 15-year-old individuals born with a 
GA below and over 37 weeks.134 Only birth weight adjusted for GA (IUGR) revealed a 
relation to adolescent BP in this study. One possible explanation for the contrast of 
results in these adolescent individuals may be that the relation between early de-
terminants of increased BP may be obscured during adolescence as also described 
by Barker et al. 12;111 
Siewert-Delle suggested that the effect of GA may be even stronger in the lower 
ranges of gestation (GA 30-38 weeks).65 The effect of IUGR may therefore be con-
cealed in our study population. In our study the regression coefficient of GA to 
adult SBP became slightly stronger when only the very preterm individuals were 
included, but significance disappeared. This may be due to a decreased number of 
individuals. However, in a larger sample the very preterm individuals of our cohort 
no relation between GA was found.133 Therefore, our data suggest that the relation 
between GA and adult SBP decreases in the lowest ranges of gestation. 
Besides the increased BP values, we also found that the prevalence of prehyper-
tensive stage was 1.5-1.6 times higher in preterms compared with controls. Indi-
viduals with prehypertensive BP are known to be at risk to develop hypertension in 
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later life.95 High prevalence of prehypertensive stage in our study population (66% 
in preterms and 45% in controls), suggest that screening at young adult age would 
possibly be effective to trace individuals at risk of adult hypertension. Early recogni-
tion of individuals at risk may help to prevent the development of hypertension and 
treatment can be introduced early. 
No relation between IUGR and prematurity and renin concentration was found. 
These findings are in contrast with the findings of other studies, showing altered 
RAS in IUGR individuals.58;59 Therefore, no contribution to this possible pathophysi-
ological mechanism of the RAS can be given with our data. The absence of the rela-
tion between renin and BP may be due to small number of individuals in our study.
Accurate measurements of BP, like ambulant 24-hour BP monitoring, are hard to 
obtain in large epidemiological studies. Therefore, BP measurements in these stud-
ies are often limited to initial screenings. In our study we were able to compare BP 
when measured by only one initial screening, or by 24 hour ambulant BP monitor-
ing. The mean systematic error in SBP and DBP after an initial screening compared 
with daytime SBP and DBP were small (0.5 mmHg and –2.9 mmHg respectively). 
This means that the mean values of both SBP and DBP in epidemiological studies 
measured on an initial screening will not deviate much from ABPM values. Results of 
studies based on initial screening BP values are therefore reasonably comparable to 
studies using ABPM values. However, the limits of agreement were high. This means 
that individual BP measurements based on an initial screening, may over- or under-
estimate the ABPM BP with 15.2 mmHg for SBP and 12.5 mmHg for DBP. Thus BP 
measurement on an initial screening for individual purposes are not recommended, 
to prevent erroneous diagnosis and inappropriate management, as also described 
previously.135 
The strength of our study was that perinatal parameters in our very preterm in-
dividuals were obtained prospectively. The retrospectively obtained data on birth 
weight and GA in controls may have introduced recall bias. Most importantly, con-
trols were only included when born at term (> 37 weeks) and normal birth weight 
(> 2500 grams). If birth weight or GA was given by mother’s recall, we assumed 
that the mother did recall prematurity or low birth weight. Individuals providing 
uncertain data on birth weight or GA were not included in the study. Therefore, the 
chance of recall bias is low. 
Second, we were able to evaluate the effect of prematurity separately from IUGR 
within the very preterm born individuals. The results indicate that very preterm 
birth affects young adult SBP, but that IUGR in very preterm individuals do not at-
tenuate this effect.
Reliable prevalence rates of hypertension (stage 1 and 2) and relative risks cannot 
be given, as the number of individuals in our study was small. Much larger samples 
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are needed to confirm our findings. Unfortunately, in our cohort no larger sample of 
very preterm SGA individuals could be included, as these were not available within 
the cohort. 
In conclusion, our results support the hypothesis that very premature birth increases 
both the mean SBP in young adults and the risk of hypertension. In our study, IUGR 
did not contribute to the increased SBP. Systematic monitoring of the BP in young 
adults born preterm may identify individuals at risk for development of hyperten-
sion. In addition, such follow-up program may reveal the clinical significance of our 
findings.
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ABSTRACT
Background: Preterms and intra-uterine growth retardated (IUGR) subjects are pre-
sumed to have an increased risk to develop renal disease at adult age. Decreased 
renal function may already be present at young adult age. 
Methods: We included 29 appropriate, 23 small for gestational age (AGA, SGA) very 
premature individuals (gestational age < 32 weeks) and 30 AGA and full term born 
controls (37-42 weeks) at age 20. Glomerular filtration rate (GFR) and effective renal 
plasma flow (ERPF) were measured by Inulin and ρ-amminohippuric acid clearances 
(ml/min/1.73m2) before and after renal stimulation with low dose dopamine infu-
sion (2 μg/kg/min) and oral amino-acid intake. Also, we assessed albumin to cre-
atinine ratio (ACR: mg/mmol) in three urine samples and sonographicly estimated 
renal size. 
Results: At baseline GFR did not differ between the three groups (SGA 107, AGA 116 
and Controls 112 ml/min/1.73m2), but ERPF was significantly lower in SGA compared 
with controls (515 vs. 586 ml/min/1.73m2). After renal stimulation GFR and ERPF 
increased significantly, but the GFR increase tended to be lower in SGA subjects 
compared with controls (12 and 20 ml/min/1.73m2). The mean value of ACR was 
significantly higher in SGA individuals compared with controls (p-value: 0.03). No 
significant difference between SGA versus AGA, and AGA versus controls was found. 
Renal size was significantly associated to renal function (p value < 0.001). 
Conclusions: Our findings support the hypothesis that preterm birth in combination 
with IUGR contributes to abnormal renal function at young adult age. 
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INTRODUCTION
The associations between low birth weight and adult hypertension, the insulin 
resistance syndrome, type II diabetes and cardiovascular events have been well 
described.13;136 It was hypothesized that unfavourable fetal and neonatal conditions 
lead to permanent alterations in organs and organ systems, resulting in an increased 
risk of disease. 137 
In intrauterine growth retardated (IUGR) individuals a decreased nephrogenesis is 
suggested to be responsible for a decrease in renal function at long-term.41 Animal 
studies have shown a decreased nephron number and an impaired renal function 
in low birth weight offspring.129;138 Also in humans a decrease in nephron number 
in low birth weight subjects has been found.117;139 However, prospective follow-up 
studies in low birth weight individuals evaluating the renal function in adult life are 
limited and inconclusive.
Recently, it has been shown that nephrogenesis ceases after very premature birth 
suggesting limited nephron number in preterms throughout life.63 As a strong rela-
tion between nephron number, renal size and albuminuria was shown in individuals 
at risk of renal diseases, very preterm subjects may be at risk to develop microalbu-
minuria and renal disease in adult life.34;45 Recently, we have found that IUGR affects 
creatinine clearance, microalbumin concentration in spot urines, and systolic blood 
pressure at the age of 19 years within subjects born very preterm 132;133. The effect of 
prematurity itself was not studied. 
We describe the effect of prematurity, IUGR and the combination of prematurity 
and IUGR on microalbuminuria, glomerular filtration rate (GFR), effective renal plas-
ma flow (ERPF) and renal functional reserve capacity (RFRC) at the age of 20 years. 
METHODS 
Study population
Three groups of young adults were recruited to participate in our study: 1. Individu-
als born very premature (< 32 weeks) and small for gestational age (SGA), 2. Indi-
viduals born very premature, and appropriate for gestational age (AGA), 3. Controls 
born full term (37-42 weeks) and appropriate for gestational age. The individuals 
who were born very premature were recruited from the participants of the POPS 
19 study (N=422) 132; A follow-up study of a Dutch birth cohort (all born in 1983) 
consisting of 94% of all live born individuals in the Netherlands with a gestational 
age < 32 weeks and/or a birth weight < 1500 grams (Project on Prematures and 
Small for gestational age infants (POPS)). Birth weight and gestational age of these 
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individuals were derived from the POPS database (TNO Quality of Life, Leiden, The 
Netherlands). Birth weight was converted to standard deviation scores (SDS) ad-
justed for gestational age using Swedish reference standards 93 and considered as 
a measure of IUGR. Recruitment of SGA individuals started with the lowest birth 
weight adjusted for gestational age (≤ -2 SDS: N=29) and AGA individuals with the 
highest birth weight adjusted for gestational age (0-2 SDS: N=205). Controls were 
born between January 1st 1982 and December 31st 1984 and recruited by advertise-
ment. Vegetarians were excluded from the study.
Data obtainment
Patient characteristics Adult weight, height and body mass index (BMI) were 
obtained and converted in standard deviation scores 94. Data on birth weight and 
gestational age of the prematurely born individuals were derived from the POPS 
database. Data on birth weight and gestational age of the controls was mainly ob-
tained from birth records, or when unavailable by mother’s recall.
Baseline renal function Participants were instructed to have a light, fructose free 
breakfast. Baseline serum creatinine, urea, sodium and potassium concentrations 
were obtained. Baseline GFR and ERPF were estimated by the mean of three 30 
minutes clearance periods with respectively Inulin (Inutest 25%, Fresenius, Austria) 
and ρ-aminohippuric acid (PAH: sodium aminohippurate 20%, MSD). A single bolus 
injection of 45 mg/kg Inulin and 8 mg/kg PAH preceded the continuous infusion 
of 42 mg/min Inulin and 20 mg/min PAH. Participants were instructed to void 45 
minutes after the bolus injection (t=0) and at t=30, t=60 and t=90 minutes. Blood 
samples were taken, from the opposite arm where medication was infused, in the 
middle of each clearance period at t=15, t=45 and t=75 minutes. 
Stimulated renal function After baseline renal function test, the participants were 
given a protein-rich lunch (containing 130 g beef-steak).124;125 At least sixty minutes 
after starting lunch and at least forty minutes after finishing lunch, a low dose 
dopamin infusion was started at a rate of 2 μg/kg/min.124 After five minutes three 
new clearance periods were started: Voiding at t=150, t=180, t=210, and t=240 and 
blood samples at t=165, t=195, and t=235. Emptying of the bladder was monitored 
estimating the residual volume in the bladder with a bladder scan directly after 
voiding. 
Calculation of GFR, and ERPF GFR and ERPF adjusted for body surface area (BSA) 
were calculated using the equation: UInul/PAH * Volume (ml) * 1.73 / PInul/PAH * duration 
(min) * BSA, in which UInul/PAH and PInul/PAH reflects the concentration (mg%) of Inulin 
or PAH in the urine and plasma respectively, and BSA the √ (height (m) * weight (kg) 
/ 3600). The filtration fraction (FF) was calculated by dividing GFR by ERPF (*100%). 
The mean of three measurements before and after renal stimulation was used in 
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the analysis. To monitor systemic effects of dopamin infusion, we obtained systolic 
and diastolic blood pressure (SBP, DBP) using a calibrated automatic blood pressure 
device (Hewlett Packard). 
Microalbuminuria Three morning urines were obtained at three consecutive days 
prior to the renal function test to measure albumin to creatinine ratio (ACR: mg/
mmol). An ACR between 1.1 and 2.2 was considered as high normal, and > 2.2 mg/
mmol as microalbuminuria.87;140
Renal ultrasound Measures of maximal bipolar kidney length and renal volume 
((π / 6) * length (cm) * width (cm) * thickness (cm)) were obtained by renal ultra-
sound. Relative renal length and volume were calculated dividing renal length by 
body height, and renal volume by BSA respectively. The mean of left and right kid-
ney size was used in the analysis.
Laboratory assays
Laboratory analyses were determined on a Hitachi 917 (Roche Diagnostics). Elec-
trolytes were measured by using Ion Selective Electrodes. Enzymatic assays were 
used for the determination of creatinine (CREA Plus®) and urea in urine and serum. 
For the determination of microalbumin in urine an immunoturbidimetric assay was 
used. Inulin and PAH concentrations were measured using the automatic Anthrone 
and Bratton-Marshall technique.126;127 
Informed Consent and Ethics Committee
Informed consent was obtained after oral and written information had been given. 
The ethics committee of the Erasmus MC – Sophia Children’s Hospital, University 
Medical Center Rotterdam approved the study protocol.
Statistics
Results are presented as mean, standard deviation (SD) and 95% confidence inter-
vals (95%CI). Linear regression analyses were performed to analyse the differences 
between the three groups in GFR, ERPF, FF, blood pressure, and diuresis before and 
after renal stimulation. Change in GFR, ERPF, and FF were adjusted for the baseline 
value. To evaluate the change in GFR, ERPF and FF after renal stimulation a paired 
t-test was used. Statistical significance was considered at the level of 5%. 
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RESULTS
Eighty-two individuals participated in the study (23 SGA, 29 AGA and 30 controls). 
In controls, data on birth weight and gestational age were subtracted from written 
birth certificates or medical records in 18 individuals (60%) and from mothers’ recall 
in 12 individuals (40%). 
In three participants (1 person in each group) renal function test was not finished 
due to adverse reaction to the study medication. Blood pressure during the renal 
function test was measured in 78 of the remaining 79 subjects, (due to very frequent 
premature heartbeats leading to unreliable blood pressure values in 1 person). Data 
on microalbuminuria was present in all participants.
Baseline characteristics of all 82 subjects are shown in table 1. Weight and height 
at age 20 were significantly lower in SGA subjects compared with AGA and con-
trols, but BMI was equal. The distribution of males and females was equal between 
groups.
Renal function test
Table 2 shows the mean (SD) values of GFR (Figure 1A), ERPF (Figure 1B), and FF in 
the three groups before and after renal stimulation, and the mean (SD) ACR and log-
arithmic values of ACR measured in three morning urines. No significant differences 
in renal functions were present between males and females (data not shown). 
Figuren horende bij Hoofdstuk 4.3 
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Figure 1: Mean Glomerular filtration rate (GFR) (Figure 1A) and Effective renal plasma flow (ERPF) (Figure 1B) at baseline and 
after renal stimulation in the three study groups. § P-value < 0.10 and † P-value < 0.05.
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Baseline measurements At baseline GFR did not differ between the three groups 
(107, 116 and 112 ml/min/1.73m2 in SGA, AGA and controls respectively). ERPF at 
baseline was significantly lower in SGA (515 ml/min/1.73m2) compared with con-
trols (586 ml/min/1.73m2). The ERPF in AGA individuals at baseline was with 534 
ml/min/1.73m2 not statistically different from both SGA and controls. FF was 1.3% 
(95%CI:-0.5;3.1) higher in SGA and 2.5% (95%CI:0.9;4.1) higher in AGA compared 
with controls. SBP during the renal function test was significantly higher in both 
SGA and AGA subjects compared with controls. DBP was not different between the 
three groups. 
Change due to stimulation GFR, ERPF, and diuresis increased significantly, and FF 
dropped in all groups (paired t-test). SBP did not change, but DBP decreased with 
4.2 mmHg (95%CI:2.7;5.7). The increase in GFR due to renal stimulation (adjusted for 
baseline GFR) tended to be smaller in SGA subjects compared with AGA and to con-
trols (crude GFR increase 11.6, 13.9 and 19.8 ml/min/1.73m2 respectively, p-value 
0.09). The increase in ERPF was not statistically different between the three groups. 
Measurements after stimulation After stimulation the mean GFR in SGA was 119 
ml/min/1.73m2, compared with 130 and 132 ml/min/1.73m2 in AGA and controls 
respectively (mean difference SGA vs. controls: 12.7 (95%CI:-1.4;26.9)). ERPF was 130 
ml/min/1.73m2 lower in SGA (95%CI:17.5;242.8) and 70 ml/min/1.73m2 lower in AGA 
(95%CI:-30;170) than controls. 
ControlsAGASGA
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Figure 2: Mean albumin creatinine ratio (ACR) (10-logarithm transformed) in the three study groups. † P-value < 0.05.
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Microalbuminuria
Microalbuminuria (ACR > 2.2) was present in 2 SGA subjects (8.7% of all SGA sub-
jects), but not in AGA subjects or controls. High normal values of ACR (1.1-2.2) were 
present in 2 SGA subjects (8.7%), 1 AGA subject (3.4%) and none of the controls. 
After logarithmic transformation of ACR (left-sided skewed) ACR was 0.24 (95%CI 
0.03;0.45) higher in SGA compared with controls (Table 2 and Figure 2). This cor-
responds with a mean difference in (geometric) ACR of 1.74 mg/mmol 1.1;2.8)).
Renal ultrasound and renal function
The mean absolute and relative kidney length and volume were all positively as-
sociated with baseline and stimulated GFR and ERPF (Table 3). An increase of 1 cm 
in bipolar kidney length increased baseline GFR with 9.2 ml/min/1.73m2 (95%CI: 
4.0;14.4), stimulated GFR with 23.1 ml/min/1.73m2 (95%CI: 6.1;18.7), baseline ERPF 
with 60.6 ml/min/1.73m2 (95%CI: 29.8;91.4) and stimulated ERPF with 102.7 ml/
min/1.73m2 (95%CI: 54.4;151.0).
DISCUSSION
It has been postulated that progressive renal function loss is characterized at first 
by single nephron (SN) hyperfiltration, or increased SN-GFR, and increased micro-
albuminuria and overt albumin leakage afterwards.141 With this increase in SN-GFR 
the renal functional reserve capacity (RFRC) is consumed, to maintain normal renal 
function, and the measured RFRC is decreased.142 Estimation of the RFRC can be 
established calculating the difference in GFR before and after afferent and efferent 
vasodilatation by ingestion of amino-acids and infusion of (low dose) dopamin re-
spectively.124 The difference in ERPF and FF can help to evaluate whether a potential 
difference in RFRC is a result of a (combination of ) decreased capacity of afferent or 
efferent vasodilatation. 
In healthy individuals maximal efferent vasodilatation (dopamin effect) leads 
to an increase in both ERPF and GFR, but as intraglomerular pressure decreases, 
ERPF rises more than GFR, and FF falls. In our study, the mean FF fell in all study 
groups, suggesting an intact capacity for efferent vasodilatation of both preterm 
and full term born individuals. The trend for a slightly decreased RFRC in the SGA 
group would therefore be a result of a decreased capacity of afferent vasodilatation 
(amino-acid effect). This may be a result of either a vascular smooth muscle relax-
ing problem, or a persistent afferent vasodilatation at baseline combined with an 
increased intraglomerular pressure. The higher baseline FF in SGA (n.s.) and AGA 
individuals (p<0.05) compared with controls suggests an increased intraglomerular 
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pressure at baseline. Therefore, we hypothesize that in the very premature partici-
pants afferent renal arteriolae are dilated at baseline, leading to a higher risk of glo-
merular damage over time. Also in AGA baseline ERPF and increase in GFR seemed 
lower compared with controls, but no significant differences were observed in our 
study. It seems that IUGR exacerbates the adverse effect of preterm birth on young 
adult renal function.
Most likely, a decreased number of nephrons in combination with afferent vasodi-
latation explains the combination of our findings: decreased ERPF with normal GFR 
at baseline (higher FF), equal increase in ERPF, and smaller increase in GFR due to 
renal stimulation in SGA compared with controls. This concurs with the finding that 
microalbuminuria was increased in prematurely and SGA born individuals.132 
Several studies demonstrated a decreased number of nephrons after IUGR and 
premature birth.63;117;129;138;139 Decreased nephron number would decrease filtration 
surface area leading to hyperfiltration, glomerular hypertension, glomerular dam-
age, eventually leading to progressive renal disease.41 The decreased renal length 
and volume in preterms and the associations between renal size and function fur-
ther support this hypothesis.34;45 
Our previous study showed similar small, but significant differences in estimated 
creatinine clearance and microalbuminuria between SGA and AGA individuals born 
very premature at the age of 19 years suggesting that the difference in renal func-
tion between SGA and controls is not only a result of IUGR, but also of prematu-
rity.132 Animal models have shown a decreased renal function after IUGR.46;129;138 In 
humans, a limited number of studies have compared renal function in preterm or 
IUGR subjects with at term born subjects.66;143 A decreased creatinine clearance and 
disturbed tubular function during childhood (6-12 years of age) was observed in 
very premature SGA and AGA born subjects (mean BW 845 g and GA 27.6 weeks).143 
Also, in 26-year-old women born prematurely (AGA), unfavourable GFR and ERPF 
was present, but no significant difference with at term born controls was detected.66 
Both studies did not measure the effect of renal stimulation on renal function. 
We hypothesize that nephron number in very preterm subjects is impaired and 
attenuated by IUGR. This leads to an impaired renal functional reserve capacity and 
long-term renal function loss. Second, an altered (renal) arterial reactivity due to in-
tra uterine stress may have resulted in both an increase in systemic and glomerular 
blood pressure leading to an affected long-term renal function. 27;58;59 Systolic blood 
pressure was significantly higher in both SGA and AGA ex-preterms compared with 
controls, but renal function was more disturbed in SGA.66;67;133, suggesting that in-
creased blood pressure precedes renal function loss in very preterm subjects, as 
also described in experimental studies.144;145
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We were able to evaluate the effect of prematurity separately from the effect of 
IUGR on adult renal function. At age 20 only the combination of prematurity and 
IUGR shows significant differences in renal function, even with limited number of 
subjects in our study. To confirm our findings, extended renal function tests are 
recommended in larger epidemiological studies. The fact that our participants are 
still young, and glomerular function decreases with increase in age, underlines the 
importance of our findings.120;122 The combination of afferent vasodilatation and 
higher systolic blood pressure increases the risk for glomerular damage even more. 
Follow-up of these very preterm subjects is recommended to detect renal function 
loss in an early phase.
In conclusion, our study indicates that both prematurity and IUGR influence adult 
renal function. It is likely that (fetal) kidney development is affected leading to an 
unfavourable renal function in young adult life. Whether these differences will in-
crease over time, and whether these differences are also present during childhood 
are important perspectives in this field of research. It is warranted to determine 
if and when screening for renal function loss in very preterm subjects is recom-
mended.
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Reduced renal length and volume 20 years after very preterm birth
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ABSTRACT 
Background: Intrauterine growth retardation is presumed to be associated with 
decreased renal size and impaired renal function as a result of impaired kidney de-
velopment and nephron deficit. We studied whether very preterm birth also affects 
renal size at young adulthood. 
Methods: Fifty-one very premature subjects (< 32 weeks of gestation), either small or 
appropriate for gestational age (22 SGA and 29 AGA), and 30 full term born controls 
were included to measure bipolar kidney length and kidney volume sonographicly 
20 years after birth. Relative kidney length (kidney length / body height) and vol-
ume (kidney volume / body surface area) were calculated. 
Results: Both absolute and relative left kidney length and volume were significantly 
lower (1.0 cm (95%CI 0.2;1.2) and 0.3 cm/m (95%CI 0.0;0.6) respectively) in preterm 
born participants compared with controls, and more obvious in females. For the 
right kidney this difference was only present in females. Renal size did not differ 
between preterm born SGA and AGA participants. In 70.0% of controls left kidney 
was larger than right, compared to 40.9% in SGA (RR 1.7 95%CI 1.0;3.0) and 48.3% 
in AGA (RR 1.5 95%CI 0.9;2.3). Renal structural anomalies were only present in 8 
premature born participants (Fisher exact P-value = 0.02). 
Conclusions: Our data suggest that kidney growth is impaired after preterm birth, 
especially on the left side, and renal structural anomalies are more frequent com-
pared with full term born controls. 
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INTRODUCTION
An increasing number of studies show an association between intrauterine growth 
retardation (IUGR) and underdevelopment of the fetal kidneys, with limited nephron 
number and decreased renal size.129;138;146;147 Additionally, data have been published 
indicating a strong relation between birth weight and renal size, nephron number, 
glomerular volume, albuminuria and systolic blood pressure.34;45 These studies un-
derline the hypothesis that subjects liable to IUGR are at risk to renal function loss, 
due to a nephron deficit, loss of filtration surface area, hyperfiltration, glomerular 
hypertension and glomerular damage.36
It has been described that nephrogenesis continues until 36 weeks of gestation. 
Therefore, it is likely that very preterm born individuals (gestational age < 32 weeks) 
have a decreased number of nephrons at birth.62 In addition, it was demonstrated 
that nephrogenesis is impaired after preterm birth.63;64 Moreover, limited postnatal 
kidney growth until the age of 18 months was also shown in individuals who were 
born premature.148 It has not been studied whether adult renal size is also impaired 
after premature birth compared with full term born individuals, or that renal catch-
up growth during childhood is present.
Our study was conducted to compare renal size in young adults born very pre-
maturely (either IUGR or with appropriate birth weight) with renal size in full term 
born controls. 
METHODS
Study population
Three groups of young adults were recruited to participate in our study. The first 
group was born very premature (< 32 weeks) and small for gestational age (SGA). 
The second group was born very premature, but appropriate for gestational age 
(AGA). The third group was born full term and appropriate for gestational age (con-
trols).
The SGA and AGA group were recruited from the database of the Project of Pre-
terms and Small for gestational age infants (POPS cohort). This cohort contains 94% 
of all subjects born alive in the Netherlands in 1983 with a gestational age < 32 
weeks and/or a birth weight < 1500 grams. In 2002-2003 63.8 % of the individuals 
alive at the age of 19 years participated in the POPS 19 study.133 In our new study all 
individuals who participated in the POPS 19 study and born with a gestational age 
< 32 weeks were eligible for inclusion.
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Perinatal parameters (i.e. birth weight and gestational age) were derived from this 
POPS database (TNO Quality of Life, Leiden, The Netherlands). Birth weight adjusted 
for gestational age was converted to standard deviation scores (BW-sds), using 
Swedish and Dutch reference standards, and considered as a measure of IUGR.93 To 
convert adult weight in standard deviation scores Dutch reference standards were 
used.94 
For the SGA group all individuals with the lowest BW-sds (<-2) were asked to par-
ticipate in our study (n=26). For the AGA group individuals with a BW-sds between 0 
and 2 were asked to participate, starting with the highest BW-sds. As the number of 
eligible individuals in the AGA group was very large (n=205), the individuals living 
closer to the hospital were recruited first. The control group, containing students 
born between January 1st 1982 and December 31st 1984, was recruited in the hospi-
tal region by advertisement. Data on birth weight and gestational age in the control 
group was collected by birth records or, when unavailable, by mother’s recall.
Informed Consent and Ethics Committee
Informed consent was obtained after oral and written information had been given. 
The ethics committee of the Erasmus MC – Sophia Children’s Hospital, University 
Medical Center Rotterdam approved the study protocol.
Renal ultrasound
Participants were invited to the Erasmus MC – Sophia Children’s hospital, Rotter-
dam, the Netherlands. Renal ultrasound was performed by one of the three pedi-
atric radiologists according to a standardized protocol. Renal size was measured in 
prone position with a Philips ATL HDI 5000 scanner with a C5-2 curved array trans-
ducer (Philips BV Nederland, The Netherlands). Measures of maximal bipolar kidney 
length, width and thickness were obtained from both right and left kidney. Renal 
width and thickness were measured at the level of the kidney hilum. Renal volume 
(ml) was calculated using the formula (π / 6) * length (cm) * width (cm) * thick-
ness (cm).149 Cortical thickness was defined as the distance between the external 
surface of the kidney and top of the medulla. As absolute renal size is known to be 
associated with body size, we calculated the relative kidney length (bipolar kidney 
length (cm) / body height (m)) and relative kidney volume (bipolar kidney length 
(ml) / body surface area (BSA, m2)).123 BSA was calculated using the equation √ (body 
height (m) * weight (kg)) / 3600). If renal or ureterovesical anomalies were noticed 
they were reported.
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Statistics
Results are presented as mean, standard deviation (SD) and 95% confidence inter-
vals (95%CI). Analyses were performed with linear regression analyses to compare 
groups, and stratified by gender. 
Intra- and interobserver variability 
Intra- and interobserver variability for the three pediatric radiologists was measured 
in 7 healthy students (5 females, 2 males). The mean (95%limits of agreement) intra-
observer variability for bipolar renal length ranged between 0.0 cm (-1.1;1.1) and 0.1 
cm (-1.0;1.2) for the left kidney and 0.1 cm (–0.7;0.9) and 0.4 cm (-0.5;1.4) for the right 
kidney. The intraclass coefficient (ICC) for intra-observer variability was 0.97 for left 
bipolar kidney length and 0.88 for right bipolar kidney length. The mean (95% limits 
of agreement) inter-observer variability for bipolar renal length ranged between 
0.0 cm (-1.4;1.5) and 0.2 cm (-1.0;1.5) for the left kidney and 0.1 cm (-0.1;0.3) and 0.2 
cm (-0.4;0.8) for the right kidney. The intraclass coefficient (ICC) for inter-observer 
variability was 0.84 for left bipolar kidney length and 0.86 for right bipolar kidney 
length. The variabilities of renal volume estimates were larger, but no significant 
systematic errors within and between observers were present.
RESULTS
Baseline characteristics of study population
Renal ultrasound was performed in 81 individuals: 22 SGA, 29 AGA and 30 controls. 
Baseline characteristics are shown in Table 1. Birth weight and gestational age were 
significantly different in the three groups. Current weight and height were lower in 
SGA individuals compared with AGA and controls, but BMI was equal. 
In controls, data on birth weight and gestational age were subtracted from writ-
ten birth certificates or medical records in 18 individuals (60%) and from mothers’ 
recall in 12 individuals (40%). Perinatal and obstetric parameters of the premature 
born individuals were known since birth and mentioned in table 2. Hypertension 
during pregnancy was present in 15 of 22 SGA (68%) and in 2 of 29 AGA (7%) indi-
viduals. Perinatal corticosteroids were administered in 2 of 22 SGA (9%) and 8 of 29 
AGA (28%) individuals. Parameters on renal function of the postnatal period were 
not obtained.
Renal size
Absolute kidney size was larger in males compared with females.123 As expected, 
left kidneys were larger than right kidneys in the majority of the controls (70%). In 
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contrast, in AGA and SGA preterms this percentage was 48% and 41% respectively. 
As shown in Table 3, SGA and AGA preterms had significant smaller absolute and 
relative left renal length and volume compared with controls. These observations 
were more obvious in females as shown in Figure 1 and 2. Absolute and relative 
right kidney volume was significantly smaller in SGA and AGA participants com-
pared with controls, but especially in females. No significant difference between 
SGA and AGA subjects in left and right kidney size was present.
Renal and ureterovesical anomalies
Subclinical anomalies of the kidneys and ureters were present in 8 of 51 subjects 
born prematurely, and not in controls (Fisher exact p-value = 0.02). Anomalies varied 
from nephrocalcinosis (n=1), unilateral pyelocaliceal dilatation (n=3), ureteropelvic 
junction obstruction (n=1), ureter dilatation (n=1), extra-renal pelvis (n=1), ureter 
duplication and ureterocèle (n=1). None of the subjects were known with these 
anomalies before the renal ultrasound was performed. No difference in prevalence 
of renal abnormalities between SGA (4/22) and AGA (4/29) individuals was present. 
DISCUSSION
We found that absolute and relative renal length and volume is decreased in 20-
year-old individuals born very prematurely. The difference in left kidney size was 
larger than the difference in right kidney size, and was more obvious in females. 
No significant effect of IUGR on renal size was found within the individuals born 
very prematurely. These results indicate that fetal kidney development is impaired 
after preterm birth and the suggested effect of IUGR on renal size is probably small 
within these very preterm born individuals. This may be due to the fact that IUGR in 
these preterms was not present during nephrogenesis, which peaks at 32nd weeks 
of gestation and continues until 36 weeks of gestation and is correlated to renal 
size.34
Recently, Singh et al. described that lower renal volume in aboriginals represents 
kidneys with reduced nephron number 34. It has been demonstrated that postnatal 
nephrogenesis in preterm born individuals is limited.63;64 Therefore, a reduced neph-
ron number after preterm birth probably persists throughout life. In 56 deceased 
extremely premature infants and 10 deceased full term born controls, nephron 
number was highly correlated to gestational age and active glomerulogenesis 
was ceased after 40 days postnatal.63 The finding that decreased nephron number 
predisposes to reduced renal function at adult age underlines the importance of 
our results.34;45 Therefore, preterm born individuals may have higher risk of renal 
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disease in later life. This finding concurs with our previous results of increased blood 
pressure and unfavourable renal function and microalbuminuria in these premature 
born individuals.132;133 
Decreased renal volume was also found in low birth weight (LBW) aboriginal chil-
dren between 5-18 years of age.146 The BSA adjusted renal volume was 78.5 ml/m2 
in 33 LBW subjects, compared with 85.7 ml/m2 in 141 normal birth weight (NBW) 
subjects (p value 0.018), but renal length was equal. It was stated that LBW in these 
subjects was a result of IUGR, but data on gestational age were unavailable in many 
participants. In contrast, we have found that IUGR preterm subjects did not have 
significant smaller renal size than non-IUGR preterm born subjects. 
In our study, renal size differences between preterms and controls were more 
obvious in the left kidney than in right kidney. Similar results were described in the 
same study in aboriginal children of Spencer et al. The relative left BSA adjusted kid-
ney volume was 83.6 ml in LBW versus 93.5 ml/m2 in NBW subjects (p-value 0.015) 
and relative right kidney volume was 73.3 ml/m2 in LBW versus 77.9 ml/m2 in NBW 
subjects (p-value 0.225).146 
Interestingly, smaller absolute left kidney volume (but not right kidney volume) 
was also present in adult subjects with chronic kidney failure and patients with hy-
pertension compared with normotensive chronic kidney failure patients.150 It was 
not studied whether renal size in these hypertensive patients was associated with 
birth weight and gestational age. In an animal model it was shown that the kid-
neys respond asymmetricly to adrenoceptor stimulation after intrauterine stress.27 
Whether this phenomenon is also present in humans, and if (fetal) kidney growth is 
affected by this is not known. 
We hypothesize that early postnatal renal growth is limited in very preterm born 
individuals, especially in left kidneys. Recently, it was demonstrated that postnatal 
renal growth after preterm birth was limited until 18 months of age, but no dif-
ference in left and right kidney growth was mentioned.148 To our knowledge, only 
one study described fetal kidney growth separately for left and right kidney.151 In 
this longitudinal study 246 normal fetal kidneys at several ages of gestation were 
sonographicly measured. No significant difference was found between left and 
right kidney growth between 16 and 38 weeks of gestation. It might be that the 
left kidney grows more rapidly than the right kidney after the gestational age of 32 
weeks in normal gestation, but larger studies are needed to confirm this finding. 
If this difference in growth is not present after very preterm birth, it might explain 
why left renal size in our very preterm cohort (<32 weeks) is more affected than the 
right side through an anatomical and embryological pathway. 
In human studies it has not been reported previously that the differences in re-
nal size between IUGR and non-IUGR individuals was more obvious in females, but 
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similar findings were reported in an experimental IUGR rat model.121 Kidney weight 
was more reduced due to IUGR in female rats (1.99 g in IUGR vs. 0.78 g in controls) 
than in male rats (3.33 g in IUGR vs. 2.79 in controls). Moreover, plasma creatinine 
levels were increased in these female IUGR rats, but not in IUGR males. These data 
indicate that males and females respond differently to IUGR, with respect to renal 
development and renal function. The data suggests that females have either smaller 
kidneys at preterm birth compared with males (limited intra-uterine renal growth 
in females), or that females are less capable of renal catch-up growth after preterm 
birth. The pathophysiological mechanism for this gender difference remains unex-
plained and needs further research. 
Renal anomalies were more frequently present in the very preterm born partici-
pants (8/51) compared with the controls (0/30). The anomalies consisted mainly of 
ectasia or dilatation of the ureters and pyelocaliceal system. None of the participants 
were known with their renal anomalies, and all subjects were asymptomatic. In pre-
terms some renal diseases, such as acute tubular necrosis and nephrocalcinosis, are 
more frequently shown, but an increased incidence of the renal anomalies we found 
was not reported previously.152;153 It is not known whether the anomalies of the py-
elocaliceal system and ureters were already present at (preterm) birth, or that renal 
development was disturbed early postnatal or throughout childhood while renal ul-
trasound during follow-up was not obtained. One possible biological pathway may 
originate from the observations that in-utero disturbance of the renin-angiotensin 
system affects normal kidney development. 49;50 The strength of our study was that 
we were able to evaluate the effect of prematurity separately from the effect of IUGR 
within the premature born individuals. The main difference in renal size was found 
between very preterm (AGA) and at term born participants. The additional effect of 
IUGR in these very preterm born subjects was small and not significant for all renal 
sizes. Therefore, we suggest that very preterm birth predisposes to decreased renal 
size at adult age, due to limited renal growth after birth. 
A limitation of the study was that three different radiologists obtained the data of 
renal size. To minimize the variability between the three radiologists renal size was 
measured according a standardized protocol and all radiologist measured subjects 
in all three groups. The mean error in measurement was comparable to other stud-
ies.154;155 Moreover, the results of renal length in controls were similar as reported by 
Miletic et al.156, indicating accurate measurements of renal size in our participants. 
In conclusion, kidney development after preterm birth is probably limited, leading 
to (relatively) smaller kidneys and a higher frequency of renal structural anomalies 
at the age of 20 years. IUGR did not attenuate these observations in these preterm 
born individuals. The differences were more obvious in left kidneys, and in females. 
Detailed measurement of renal development, in both size and histological changes, 
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in a large epidemiological study design is required to underline the pathophysi-
ological mechanism of unilateral decreased renal growth after very preterm birth.
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GENERAL DISCUSSION
The aim of the work described in this thesis was to evaluate early determinants of 
blood pressure, renal function and renal size in young adult individuals who were 
born very premature. In this chapter the six research questions, as formulated in the 
general introduction, are answered. Future perspectives and clinical implications 
of the findings are discussed afterwards. The main findings of this thesis are sum-
marized in the textbox below. 
Two studies were carried out between April 2002 and November 2004 in The Neth-
erlands to answer the research questions. The POPS 19 study is a follow-up study 
at the age of 19 years of a national birth cohort consisting of individuals who were 
born very premature (GA < 32 wk) and/or with very low birth weight (< 1500 g). 
Estimated GFR, microalbuminuria and blood pressure values were obtained in 422 
individuals (only GA < 32 wk) at the age of 19 years. The POPS Nephrology study 
contained 52 of these participants (23 SGA and 29 AGA) and 30 full term born con-
MAIN FINDINGS
•  The mean systolic blood pressure and prevalence of hypertension is increased 
in individuals who were born very premature compared with full term born con-
trols.
•  IUGR does not affect blood pressure within individuals who were born very pre-
mature.
•  Glomerular filtration rate is unfavorable influenced and microalbuminuria is in-
creased in individuals who were born very premature and after IUGR, compared 
with individuals who were born premature with appropriate birth weight.
•  Renal functional reserve capacity and effective renal plasma flow are decreased 
in individuals who were born very premature and IUGR compared with full term 
born controls, suggesting impaired nephron number with single nephron hyper-
filtration due to persistent afferent vasodilatation.
•  Renal size is decreased in individuals who were born very premature, compared 
with full term born controls. Left kidneys seem more affected than right kidneys, 
and women more than men. 
•  The number of renal anomalies in our study is higher in individuals who were born 
very premature compared with full term born controls.
• Renal size is associated with renal function in our study population.
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trols at the age of 20 years. Data on renal function (GFR and ERPF) before and after 
renal stimulation, microalbuminuria, renal ultrasound and 24-hour ambulant blood 
pressure monitoring were obtained. 
Blood pressure in young adult individuals who were born very premature.
1.  Is IUGR a predisposing factor for increased blood pressure at young adult age 
within individuals who were born very premature? 
2.  Is blood pressure increased at young adult age in individuals who were born very 
premature and IUGR compared with individuals who were born very premature 
with appropriate birth weight, and with full term born controls? 
An inverse association between birth weight and cardiovascular risk and adult hy-
pertension has been described frequently in the past.11;12;14;90;91 In these studies indi-
viduals born at term with low birth weight had higher blood pressure values at adult 
age than subjects with higher birth weight. This effect was attenuated by acceler-
ated (early) postnatal growth until the age of 1 year.7 Underdevelopment of organs 
and organ systems (such as kidneys, pancreas and vascular system) in individuals 
born after IUGR may lead to permanent alterations in these organs and increase the 
susceptibility of adult disease.23 A limited number of nephrons is demonstrated in 
subjects born after IUGR, which may increase systemic and intraglomerular blood 
pressure to maintain normal renal function, but renal damage and function loss 
may occur (‘hyperfiltration’ theory).36;37;157 
As kidneys develop until the last phase in pregnancy62, and postnatal nephron de-
velopment in these very preterm born individuals is probably limited63;64, it is likely 
that preterm birth alone is also accompanied with a decreased number of nephrons 
throughout life. The effect of gestational age and of IUGR within very premature 
born individuals on the development of adult hypertension was evaluated in only 
a few studies.67;68 
The results from the POPS 19 and POPS Nephrology studies both have demon-
strated that young adult systolic blood pressure was increased in individuals who 
were born very premature, but that IUGR did not affect blood pressure within these 
very preterm born individuals. (Chapter 3.2 and 4.2) In both studies the mean sys-
tolic blood pressure of the very preterm born individual was 123 mmHg, compared 
with 120 mmHg in full term born participants of the POPS Nephrology study. Also, 
the prevalence of hypertension was higher in the very premature born individu-
als (10% in the POPS 19 study, and 6% in the POPS Nephrology study). Within the 
very preterm born participants potential confounding variables, such as maternal 
hypertension during pregnancy and maternal smoking during pregnancy, did not 
affect adult blood pressure.(Chapter 3.2) Furthermore, no effect of (early) postnatal 
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catch-up growth was found within this very preterm born cohort. The best predict-
ing factor for adult blood pressure in our cohort was current weight. (Chapter 3.2) 
This was evaluated by using a regression model with the ‘unexplained residuals’ for 
adult weight dependent on birth weight (Chapter 2), to prevent improper adjust-
ment for adult weight (causal pathway). 
Nowadays, in individuals who were born very preterm or small for gestational 
age and develop short stature during childhood and adolescence, growth hormone 
therapy is frequently used to increase adult height. However, it is not known wheth-
er this increase in adult height, and thus weight, will influence the risk of high blood 
pressure. Within the participants of the POPS studies (all born in 1983), growth 
hormone therapy was not used for this purpose yet. New studies are indicated to 
elucidate the effect of growth hormone therapy in SGA premature individuals on 
adult blood pressure.
In summary, small differences in systolic blood pressure as a result of very premature 
birth, but not IUGR, are already detectable at young adult age, but current weight 
predicts adult blood pressure best.
Renal function in young adult individuals who were born very premature.
3.  Is IUGR a predisposing factor for decreased renal function at young adult age 
within individuals who were born very premature? 
4.  Are renal function and renal functional reserve capacity (RFRC) impaired in in-
dividuals who were born very premature and IUGR compared with individuals 
who were born very premature with appropriate birth weight, and with full term 
born controls at young adult age?
Decreased renal function and nephron number after IUGR birth was demonstrated in 
several experimental and a few human studies.45;46;113;114;157 As mentioned above, evi-
dence is accumulating that IUGR and nephron endowment have an important role 
in the development of adult hypertension and renal disease in adult life. 34;36;37;42;43;157 
Also in low birth weight children higher relapse rates of nephrotic syndrome have 
been reported.158 In IgA nephropathy the percentage of sclerotic glomeruli is higher 
combined with an increased blood pressure in low birth weight children.159 Stud-
ies evaluating the effect of prematurity on future renal function remain scarce and 
inconclusive.66;143 
In the POPS 19 study it was demonstrated that small but significant differences 
in renal function (estimated GFR and microalbuminuria) were present between the 
individuals who were born very premature and small for gestational age (SGA) and 
the premature born participants with appropriate birth weight (AGA): Lower GFR 
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and higher microalbuminuria. (Chapter 3.3) These differences in (baseline) GFR were 
similar, but not significant, in the POPS Nephrology study.(Chapter 4.3) In the latter 
study the increase in GFR after renal stimulation tended to be lower in the SGA 
participants compared with controls. These data suggest that at the age of 20 years 
single nephron (SN) hyperfiltration is present at baseline, and thus a decreased 
RFRC, in the SGA premature born individual. The capacity of efferent renal vaso-
dilatation due to dopamine infusion was intact in all groups, as the FF fell, and the 
increase in ERPF was equal. SN hyperfiltration may therefore better be explained by 
a decreased capacity of afferent vasodilatation, which may originate from a situa-
tion of persistent baseline afferent vasodilatation, resulting in a limited or absent 
effect of amino-acids. Persistent baseline afferent vasodilatation is accompanied 
with an increased intraglomerular pressure (increasing the risk of renal damage and 
renal function loss in later life)41;160, which concurs with the finding that baseline 
FF was higher in the premature participants compared with controls. (Chapter 4.3) 
SN hyperfiltration is probably needed to maintain a normal GFR, and an indication 
that the number of nephrons is decreased, which also fit with the observations that 
baseline ERPF was lower in SGA preterms compared with full term born controls. In 
addition, microalbuminuria was more overt in SGA preterms compared with AGA 
preterms. (Chapter 3.3 and 4.3)
The decreased RFRC, ERPF with persistent afferent vasodilatation, increased mi-
croalbuminuria and systolic blood pressure at this young age, and the knowledge 
that renal function decreases during life, suggests that very premature SGA born 
individuals are at increased risk for progressive renal disease during life.120;122 Fu-
ture prospective studies of these individuals are warranted to evaluate their renal 
function over time. Additional studies on the effectiveness of screening programs 
for secondary prevention of progressive renal disease in this population may be of 
important value. 
Renal size in young adult individuals who were born very premature
5.  Do individuals who were born IUGR and / or prematurely have smaller (relative) 
kidney size at young adult age compared with full term born controls?
In Aboriginal communities a strong relation between birth weight and renal size, 
nephron number, albuminuria and systolic blood pressure has been shown.34 Re-
nal size was also reduced in low birth weight aboriginal children, suggesting an 
increased risk of renal diseases during life.34;146
To evaluate whether renal size at young adult age was impaired in individuals who 
were born very premature and IUGR we estimated renal size with a renal sonogra-
phy in the participants of the POPS Nephrology study.(Chapter 4.4) It was demon-
strated that both absolute and relative renal length and volume were smaller in 
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the individuals who were born very premature (either SGA or AGA) compared with 
controls. Surprisingly, these differences were more obvious in the left kidney and in 
women. Though some other studies have found a similar effect of IUGR and gender 
on kidney size, no underlying mechanism is known.146;161 Two mechanisms are sug-
gested to be involved. First, left and right fetal kidney growth may differ during 
the three trimesters of pregnancy and may therefore be affected asymmetricly in 
IUGR and preterm born individuals. However, no conclusive studies on fetal kidney 
growth are available. Additionally, postnatal kidney growth may also be impaired 
after IUGR and very preterm birth.148 Second, the left and right kidney may respond 
asymmetricly to adrenoceptor stimulation after intrauterine stress, as shown in an 
animal model.27 Whether this phenomenon is also present in humans, and whether 
(fetal) kidney growth is also affected by these stimuli is not known. Further studies 
are warranted. 
Interestingly, the number of renal anomalies in the very preterm born individuals 
was higher compared with the controls. Renal anomalies mainly consisted of ectasia 
or dilatation of the ureters and the pyelocaliceal system, suggesting a disturbance 
in renal development. As it is not known whether these anomalies were already 
present at birth, we cannot determine whether this disturbance in renal develop-
ment was induced prenatal or postnatal. Potential prenatal causes of impaired renal 
development may include maternal medication use, such as medications inhibiting 
the RAS, corticosteroids and gentamycin. Administration of these drugs and inad-
equate postnatal nutrition (such as deficiency of Vitamin A) in the postnatal period 
also could have influenced renal development.28;49-52. Future studies should focus on 
such determinants affecting prenatal and postnatal renal development (in size and 
structure) in premature and at term born individuals. 
Associations
6.  Is there an association between renal size, renal function, renal functional reserve 
capacity, and blood pressure in very preterm born individuals and in controls? 
or Do subjects with an increased blood pressure also have a decreased renal 
function and a decreased renal size? 
In the studies described in this thesis it was demonstrated that increased blood 
pressure and a decreased renal size was present in both SGA and AGA preterm born 
individuals compared with controls (Chapter 4.4). Renal function was decreased 
most in SGA preterm individuals (Chapter 3.3 and 4.3). Renal size was significantly 
associated with renal function, but not with blood pressure.(Chapter 4.3). Renal 
function was not related to blood pressure either. 
These results indicate that rise in blood pressure and renal function loss does not 
develop simultaneously in these individuals: blood pressure increase precedes renal 
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function loss. These observations were also shown in some animal studies.144;145 In 
uninephrectomized rats blood pressure increased before renal function decreased 
compared with control rats.144 As blood pressure was high in AGA subjects, this 
would suggest that these individuals are also at increased risk for renal function 
loss. The most plausible explanation would be that nephron number at birth is im-
paired in very premature born individuals, but more in SGA than in AGA preterms. 
However, it is possible that the increase in blood pressure and decrease in renal 
function after IUGR birth do not origin from the same biological mechanism.33 
Other parameters of the Metabolic syndrome within the POPS 19 study
Besides blood pressure and renal function, other parameters of the metabolic 
syndrome were also studied within the POPS 19 study. It was demonstrated that 
the insulin resistance at the age of 19 years in very preterm born individuals was 
predicted by rapid postnatal weight gain until 3 months post term and by adult 
body composition.162 In contrast, no association between birth weight (SDS), early 
postnatal growth or gestational age and lipid profile or intima-media thickness of 
the carotid arteries at 19 years of age was found.163 
In summary, the studies described in this thesis suggest that premature birth affects 
renal function and blood pressure at (young) adult age, and especially when born 
both SGA and premature. Minor differences are already detectable at young adult 
age. The biological mechanism is likely to originate from a decreased renal develop-
ment, with alterations of vascular structure and limited nephron number. 
FUTURE PERSPECTIVES 
Other pathways than nephron endowment, such as programming of the hypotha-
lamic-pituitary-adrenal axis and glucocorticoid receptor, dysfunction of the pan-
creatic β-cells, RAS, and endothelium, may also be involved in the development of 
hypertension and renal disease.20;58;59;164;165 Additional analyses within the POPS 19 
participants will be addressed in order to evaluate whether associations between 
blood pressure, GFR, microalbuminuria and other parameters of the metabolic 
syndrome (such as insulin sensitivity, dyslipedemia, fat distribution, and obesity, 
intima-media thickness), and genetic polymorphisms are present.166-168 
Future follow-up of participants of the POPS studies may be very useful in the 
evaluation of progress in renal function loss over time. Furthermore, measurements 
of renin and angiotensin I and II concentration in newborns of all birth weights and 
ranges of gestation and prospective evaluation of their renal function and blood 
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pressure might improve insight in the influence of the RAS in the ‘developmental 
origins of adult health and disease’ hypothesis. 58;59 Also, insight in optimal nutrition 
in the very preterm born individual would give the opportunity to improve postna-
tal growth and (organ) development. Finally, to understand the differences in left 
and right renal size evaluating normal renal growth would be of great value. 
CLINICAL IMPLICATIONS
Prevention should focus primary on optimal fetal and early postnatal nutrition 
and prevention of premature birth. Secondary prevention can be established by 
follow-up of very premature born and low birth weight individuals, to trace and 
treat early signs of renal damage and hypertension. Minimal-invasive methods such 
as measurement of microalbuminuria in triplet urine spots, measurement of blood 
pressure, and estimation of GFR by obtaining blood samples to measure serum cre-
atinine levels should be considered. Microalbuminuria, hypertension and decreased 
GFR should be monitored. Treatment with angiotensin converting enzyme (ACE) 
inhibitors or Angiotensin II receptor blockade drugs may be needed in individuals 
with persistent microalbuminuria and hypertension. Treatment with ACE inhibitors 
has demonstrated a decrease in the amount and progression of microalbuminuria 
and may therefore also prevent renal function loss.169 Finally, birth characteristics 
should be obtained in all medical interviews evaluating the individual risk profile for 
cardiovascular and end-stage renal disease.
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SAMENVATTING
Bij verschillende studies is gesuggereerd dat groeiachterstand van het kind tijdens 
de zwangerschap leidt tot een verhoogde kans op het ontwikkelen van ziekten op 
latere leeftijd, zoals bijvoorbeeld hoge bloeddruk, vetzucht, hart- en vaatziekten, 
suikerziekte, en nierziekten. De achterliggende gedachte is hierbij dat bepaalde or-
ganen of orgaansystemen (zoals alvleesklier, nieren en de bloedvaten) onvoldoende 
zijn ontwikkeld op het moment van de geboorte, en dat deze achterstand niet meer 
wordt ingehaald. Aanpassingen van deze organen, om te kunnen overleven op de 
korte termijn, zouden op relatief jonge leeftijd leiden tot minder goede functie en 
(versnelde) schade. Deze hypothese is ook wel bekend als de ‘Barker’ hypothese, of 
de ‘Fetal origins of adult disease’ hypothese, of de ‘Developmental origins of adult 
health and disease’ hypothesis.
Tot nu toe is weinig onderzoek verricht naar de effecten van vroeggeboorte, 
groeiachterstand en de combinatie daarvan op de nierfunctie en bloeddruk op de 
langere termijn.   
In dit proefschrift zijn de bevindingen met betrekking tot vroeggeboorte, groei-
achterstand, nierfunctie en bloeddruk beschreven naar aanleiding van een alge-
meen onderzoek en een vervolgonderzoek bij jong volwassenen. 
Het algemene onderzoek is bekend als de POPS 19 studie: aan alle nog in leven 
zijnde 959 personen die in 1983 meer dan 8 weken te vroeg zijn geboren, en / of 
een extreem laag geboortegewicht hadden (< 1500 gram) is gevraagd om deel te 
nemen aan een landelijke studie waarin zou worden gekeken naar de algemene 
gezondheid (waaronder bloeddruk en nierfunctie) op de leeftijd van 19 jaar (POPS 
19 studie: Hoofdstuk 3). 
Uiteindelijk hebben 596 personen aan dit algemene onderzoek meegedaan. Van 
deze 596 personen waren 422 personen geboren met een zwangerschapsduur kor-
ter dan 32 weken (groep 1), en 274 personen met een zwangerschapsduur langer 
dan 32 weken, echter met een geboortegewicht van minder dan 1500 gram (groep 
2). Een aantal personen uit groep 1 is gevraagd aan het vervolgonderzoek deel te 
nemen (52 personen). In dit vervolgonderzoek zijn met een preciezere methode 
dan gehanteerd bij het algemene onderzoek de bloeddruk en nierfunctie gemeten. 
Bij dit onderzoek zijn tevens 30 personen betrokken die tussen 1982 en1984 gebo-
ren zijn en die niet te vroeg geboren zijn. (POPS Nefrologie studie: Hoofdstuk 4)
Uit het algemene onderzoek en het vervolgonderzoek is gebleken dat de gemid-
delde bloeddruk van de personen die te vroeg geboren zijn hoger is dan bij diege-
nen die niet te vroeg geboren zijn. Het geboortegewicht heeft geen invloed op de 
gemiddelde bloeddruk. 
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De nierfunctie is minder gunstig bij de te vroeg geboren personen, waarbij de 
nierfunctie nog minder gunstig is naar mate men een lager geboortegewicht heeft. 
Dit uitte zich ook door meer eiwituitscheiding in de urine. 
Daarnaast zijn de nieren kleiner en vaker afwijkend bij de te vroeg geboren per-
sonen. Het is goed mogelijk dat dit te maken heeft met een minder goede ontwik-
keling van de nieren voor of vlak na de geboorte.
De uitkomsten van de onderzoeken suggereren dat de nieren van te vroeg gebo-
renen met een laag geboortegewicht minder reserve hebben, waarbij waarschijnlijk 
een hogere druk bestaat in de nieren, waardoor de kans op nierschade op relatief 
jonge leeftijd groter is. Dit zou kunnen verklaren waarom deze personen meer eiwit 
in de urine hebben. 
Verminderde nierfunctie kan leiden tot schade aan de nieren, hetgeen kan leiden 
tot verdere vermindering van de nierfunctie. De verwachting bestaat daarom dat 
op latere leeftijd de verschillen in nierfunctie tussen de personen die wel en die niet 
te vroeg geboren zijn groter zullen worden.  
Het is dan ook verstandig om bij alle personen die extreem vroeg geboren zijn 
vanaf jong volwassen leeftijd regelmatig onderzoek te doen naar de nierfunctie 
(door bijvoorbeeld bloed- en urineonderzoek) omdat vroegtijdig starten van een 
behandeling kan bijdragen aan een minder snelle voortgang van het verlies aan 
nierfunctie.
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NAWOORD
Met veel plezier heb ik de afgelopen jaren gewerkt aan de onderzoeken zoals be-
schreven in dit proefschrift. Door mee te werken aan verschillende onderzoekspro-
jecten tijdens mijn studie en het eerste jaar na mijn afstuderen, en het enthousiasme 
dat daarbij op mij is overgedragen, heb ik deze weg bewandeld. Ik beschouw het 
dan ook als een eer dat dit werk uiteindelijk heeft geleid hebben tot een proefschrift 
ter verkrijging van de graad van doctor.
Bij de uitvoering van het POPS 19 onderzoek zijn meerdere instanties betrok-
ken geweest. Hierbij is de inzet van vele personen met ieder zijn eigen expertise 
(logistieke coördinatie, werving van studiedeelnemers, verzamelen van gegevens, 
nefrologie, epidemiologie en statistiek) van groot belang geweest om tot een mooi 
resultaat te kunnen komen. Dank aan eenieder die een bijdrage heeft geleverd.
Bij het ‘deelproject nieren’, de POPS Nefrologie studie, zijn meerdere afdelingen 
en dus personen van het ErasmusMC-Sophia betrokken geweest om het onderzoek 
logistiek voor elkaar te krijgen. Ik denk daarbij onder andere aan de personen die 
tussendoor een echo inplanden en verrichtten, biefstukken bakten, cito nierfuncties 
bepaalden, de bloeddrukmeters uitleenden en ‘tijdig’ bij de patiënten vele bloed- 
en urinemonsters afnamen. Ik waardeer deze inzet enorm.
Ik heb de mogelijkheid gekregen om met mijn eigen ideeën onderzoek uit te 
voeren, ondertussen klinische vaardigheden op te doen in de kindergeneeskunde 
op de spoedeisende hulp en onderwijs en cursussen te volgen in de epidemiologie. 
De combinatie van leuk werk en ondertussen veel lol met vrienden, kamergenoten, 
andere collega’s, en klinische en niet-klinische supervisoren, alias ‘bazen’, zijn voor 
mij de belangrijkste drijfveren geweest om tot een mooi einde van dit onderzoeks-
project te kunnen komen. De steun en oneindig vertrouwen die ik hierbij van mijn 
thuisfront heb (gekregen) zijn voor mij zeer waardevol.
Als er iets te vieren valt, dan geef je een feestje…..
Muziek!
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